Live financial news intelligence

Track market-moving stories before they get noisy

Real-time pulse of financial headlines curated from 5 premium feeds.

Latest market signal English
Coverage 170,753 Raw stories ingested 22,606 rewritten in CS_CZ • 0 to rewrite (last 2 days).
Agents 7 waiting Pipeline agents
  • FMP Stock News Fetch every minute 22s ago
  • FMP Forex News Fetch every 5 min 2m ago
  • CoinGecko News Fetch every 5 min 4m ago
  • FIO Stock News Fetch every 10 min 3m ago
  • Patria Stock News Fetch every 10 min 3m ago
  • Editorial rewrite Rewrite every minute 22s ago
  • Asset sync Assets every 1 hour 42m ago

Latest coverage

Market News Feed

Scan headlines quickly, then expand any story for source context.

View
Clear
Details Date Content Source
2026-06-12 16:04 2mo ago
2026-04-21 11:01 4mo ago
Analysts Estimate Northern Oil and Gas (NOG) to Report a Decline in Earnings: What to Look Out for
NOG Northern Oil & Gas
FMP Stock News
Original source text
Wall Street expects a year-over-year decline in earnings on lower revenues when Northern Oil and Gas (NOG - Free Report) reports results for the quarter ended March 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.

The earnings report, which is expected to be released on April 28, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis independent oil and gas company is expected to post quarterly earnings of $0.80 per share in its upcoming report, which represents a year-over-year change of -39.9%.

Revenues are expected to be $523.52 million, down 9.3% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 24.8% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Northern Oil and Gas?For Northern Oil and Gas, the Most Accurate Estimate is the same as the Zacks Consensus Estimate, suggesting that there are no recent analyst views which differ from what have been considered to derive the consensus estimate. This has resulted in an Earnings ESP of 0%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination makes it difficult to conclusively predict that Northern Oil and Gas will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Northern Oil and Gas would post earnings of $0.71 per share when it actually produced earnings of $0.83, delivering a surprise of +16.90%.

Over the last four quarters, the company has beaten consensus EPS estimates four times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Northern Oil and Gas doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
2026-06-12 16:04 2mo ago
2026-04-22 09:56 4mo ago
Northern Oil and Gas to Report Q1 Earnings: What's in Store?
NOG Northern Oil & Gas
FMP Stock News
Original source text
Key Takeaways NOG to report Q1 on April 28 with estimated EPS of 80 cents and $523.5M in revenues, both down YoY.Northern Oil and Gas faces weak prices, deferrals, rising costs and wider differentials, squeezing margins.NOG may see upside from gas output growth, lower well costs, hedging and a 2.6% rise in volumes. Northern Oil and Gas, Inc. (NOG - Free Report) is set to release first-quarter 2026 results on April 28. The Zacks Consensus Estimate for earnings is pegged at 80 cents per share, and that for revenues is pinned at $523.5 million.

Let us delve into the factors that are likely to have influenced this oil and gas exploration and production company’s performance in the to-be-reported quarter. But first, it is worth taking a look at NOG’s performance in the last reported quarter.

Highlights of NOG’s Q4 EarningsIn the last reported quarter, this Minnetonka, MN-based independent energy company’s earnings topped the Zacks Consensus Estimate, driven by strong production, with total output beating the consensus mark by 4.2%. It reported adjusted earnings per share of 83 cents, which beat the Zacks Consensus Estimate of 71 cents. However, revenues of $447.7 million missed the Zacks Consensus Estimate of $515 million.

The company’s earnings beat the Zacks Consensus Estimate in each of the last four quarters, resulting in an average surprise of 29.7%.

This is depicted in the graph below:

NOG’s Trend in Estimate RevisionThe Zacks Consensus Estimate for first-quarter 2026 earnings has witnessed four upward and two downward movements in the past 30 days. The estimated figure indicates a 39.9% year-over-year decrease. The Zacks Consensus Estimate for revenues indicates a 9.3% decrease from the year-ago period.

Factors to Consider for NOG’s Q1 PerformanceNorthern Oil and Gas faces near-term pressure from weak commodity prices and operator-driven activity deferrals, which are already impacting production visibility. Management highlighted a typical first-quarter downtick due to weather, curtailments and lower activity. Rising gas exposure comes with weaker realizations, and widening oil differentials further compress margins. Additionally, ongoing non-cash impairments tied to lower oil prices and higher maintenance costs signal underlying stress, while the uncertain timing of deferred wells and inconsistent operator behavior add volatility to near-term earnings outcomes. The increase in NOG’s costs might have dented its to-be-reported bottom line. According to our model prediction, the company’s first-quarter total operating expenses are likely to total $636.2 million, which is up 70.6% from the year-ago quarter’s level.

Despite headwinds, strong gas production growth, lower well costs and high-grading of drilling locations could support upside. Front-loaded capital deployment and ground game success may drive better-than-expected volumes, while hedging and cost discipline help sustain margins, positioning the company for a potential earnings beat. According to our model, NOG's total average daily production volume is expected to increase 2.6% year over year, reaching 138.5 thousand barrels of oil equivalent per day (Mboe/d).

What Does Our Model Predict for NOG?Our proven model does not conclusively predict an earnings beat for Northern Oil and Gas this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. This is not the case here.

NOG currently has an Earnings ESP of 0.00% and a Zacks Rank #3. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Stocks to ConsiderHere are some firms from the other space that you may want to consider, as they have the right combination of elements to post an earnings beat this season.

ARC Resources Ltd. (AETUF - Free Report) has an Earnings ESP of +21.55% and sports a Zacks Rank #1 at present. The firm is scheduled to release earnings on April 28. You can see the complete list of today’s Zacks #1 Rank stocks here.

ARC Resources is engaged in the exploration, acquisition and development of oil and natural gas properties in western Canada. AETUF’s earnings missed the Zacks Consensus Estimate in one of the trailing four quarters, beat the same in two and were in line in one of the quarters, delivering an average surprise of 2.2%.

Enterprise Products Partners L.P. (EPD - Free Report) currently has an Earnings ESP of +1.91% and a Zacks Rank of 2. It is scheduled to release its first-quarter 2026 earnings on April 28.

The Zacks Consensus Estimate for EPD’s 2026 EPS indicates 7.5% year-over-year growth. Valued at around $79.8 billion, EPD’s shares have gained 21.3% in a year.

Antero Resources Corporation (AR - Free Report) has an Earnings ESP of +5.46% and a Zacks Rank #2 at present. The firm is scheduled to release earnings on April 29.

Antero Resources is an independent exploration and production company focused on the development of natural gas, NGLs and oil resources primarily in the Appalachian Basin. The Zacks Consensus Estimate for 2026 EPS indicates 137.4% year-over-year growth. Valued at around $11.3 billion, AR’s shares have risen 13.3% in a year.
2026-06-12 16:04 2mo ago
2026-04-28 16:10 4mo ago
NOG Announces First Quarter 2026 Results
NOG Northern Oil & Gas
FMP Stock News
Original source text
MINNEAPOLIS--(BUSINESS WIRE)--NOG Announces First Quarter 2026 Results.
2026-06-12 16:04 2mo ago
2026-04-28 20:01 4mo ago
Northern Oil and Gas (NOG) Q1 Earnings and Revenues Surpass Estimates
NOG Northern Oil & Gas
FMP Stock News
Original source text
Northern Oil and Gas (NOG - Free Report) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.71 per share. This compares to earnings of $1.33 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +4.23%. A quarter ago, it was expected that this independent oil and gas company would post earnings of $0.71 per share when it actually produced earnings of $0.83, delivering a surprise of +16.9%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Northern Oil and Gas, which belongs to the Zacks Oil and Gas - Exploration and Production - United States industry, posted revenues of $539.86 million for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 5.57%. This compares to year-ago revenues of $576.95 million. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Northern Oil and Gas shares have added about 25.2% since the beginning of the year versus the S&P 500's gain of 4.8%.

What's Next for Northern Oil and Gas?While Northern Oil and Gas has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Northern Oil and Gas was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.73 on $538.33 million in revenues for the coming quarter and $3.04 on $2.14 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Oil and Gas - Exploration and Production - United States is currently in the top 4% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, Ring Energy (REI - Free Report) , has yet to report results for the quarter ended March 2026.

This independent oil and gas company is expected to post quarterly earnings of $0.03 per share in its upcoming report, which represents a year-over-year change of -40%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Ring Energy's revenues are expected to be $70.9 million, down 10.4% from the year-ago quarter.
2026-06-12 16:04 2mo ago
2026-04-29 14:11 4mo ago
Northern Oil and Gas, Inc. (NOG) Q1 2026 Earnings Call Transcript
NOG Northern Oil & Gas
FMP Stock News
Original source text
Northern Oil and Gas, Inc. (NOG) Q1 2026 Earnings Call Transcript
2026-06-12 16:04 2mo ago
2026-05-06 12:47 4mo ago
Northern Oil Q1 Earnings & Revenues Beat Estimates, Down Y/Y
NOG Northern Oil & Gas
FMP Stock News
Original source text
Key Takeaways NOG Q1 EPS of 74 cents beat estimates on strong output, but fell from $1.33 a year ago.Revenues of $539.9M beat estimates but declined Y/Y due to lower oil and gas sales.Production rose 10% to 148,303 Boe/d, while operating expenses surged 77% to $660M. Northern Oil and Gas, Inc. (NOG - Free Report) reported first-quarter 2026 adjusted earnings per share of 74 cents, which beat the Zacks Consensus Estimate of 71 cents. The outperformance reflects strong production. However, the bottom line declined from the year-ago adjusted profit of $1.33 due to weaker natural gas prices and a 77% increase in operating expenses.

The Minnetonka, MN-based oil and gas exploration and production company reported oil and gas sales of $539.9 million, beating the Zacks Consensus Estimate of $511 million, supported by higher crude oil realizations. However, the top line decreased from the year-ago figure of $576.9 million. The year-over-year decline was mainly due to lower oil and gas sales during this quarter.

In February, NOG closed the joint Ohio Utica acquisition of upstream and midstream assets with an adjusted ownership split of 40% for $464.6 million, including the previously paid $58.8 million deposit.

In March, NOG completed a common stock offering of 8.3 million shares of common stock, generating net proceeds of $227.9 million. Funds raised in the offering were applied to the outstanding borrowings on the company’s revolving credit facility.

NOG’s Q1 Production DetailsThe first-quarter production increased 10% year over year to 148,303 barrels of oil equivalent per day (Boe/d). Additionally, the figure beat our estimate of 141,049 Boe/d.

While oil volume totaled 73,567 Bod (a 6% decrease year over year), natural gas (and natural gas liquids) amounted to 448,444 thousand cubic feet per day (a 33% increase). Our model estimate for oil volume and natural gas production was pegged at 70,000 Bod and 411,400 thousand cubic feet per day, respectively.

The average sales price for crude was $66.32 per barrel, indicating a 2% increase from the prior-year quarter’s level of $64.92. Moreover, the figure beat our expectation of $52.51 per barrel.

The average realized natural gas price was $2.50 per thousand cubic feet compared with $3.86 in the year-earlier period. Our model estimate for the same was pinned at $4.58 per thousand cubic feet.

NOG’s Costs & ExpensesTotal operating expenses in the quarter rose to $660 million from $372.8 million in the year-ago period. This was mainly on account of a surge in production expenses, general and administrative expenses, impairment of oil and gas assets, and other expenses. The metric came above our estimate of $636.2 million.

Capital Expenditures of NOGThe company reported capital expenditures of $270.1 million for the first quarter, excluding non-budgeted acquisitions and other unplanned items. Of this total, $226.5 million was dedicated to drilling and completion activities on organic assets, while $43.6 million was allocated to Ground Game efforts, including associated development costs.

During the first quarter, NOG placed 17.1 net wells into production.

NOG’s Financial PositionThis Zacks Rank #3 (Hold) company’s free cash flow for the quarter totaled $30.4 million.

As of March 31, 2026, Northern Oil had $37 million in cash and cash equivalents. The company had a long-term debt of $2.6 billion, with a debt-to-capitalization of 58.8%.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Important Energy Earnings at a GlanceWhile we have discussed NOG’s first-quarter results in detail, let us take a look at three other key reports in the energy space.

Patterson-UTI Energy, Inc. (PTEN - Free Report) reported a first-quarter 2026 adjusted net loss of 6 cents per share, narrower than the Zacks Consensus Estimate of a 10-cent loss. However, the bottom line decreased from the year-ago quarter's breakeven result due to a decrease in operating income in its Drilling Services, Completion Services and Drilling Products segments.

Total revenues of $1.1 billion beat the Zacks Consensus Estimate by 3.1%. This was driven by higher-than-expected revenues from the Drilling Services and Completion Services segments. The Drilling Services and Completion Services segments reported revenues of $351.7 million and $679.6 million, which beat the consensus mark of $350 million and $37.1 million, respectively. However, the top line decreased about 12.8% year over year. This underperformance can be attributed to the decrease in year-over-year segment revenues.

As of March 31, 2026, the company had cash and cash equivalents worth $337.2 million and long-term debt of $1.2 billion. Its debt-to-capitalization was 27.8%.

NOV Inc. (NOV - Free Report) reported first-quarter 2026 adjusted earnings of 15 cents per share, which missed the Zacks Consensus Estimate of 17 cents. The bottom line also decreased 21% from the year-ago quarter’s 19 cents.

The oil and gas equipment and services company’s total revenues of $2.05 billion beat the Zacks Consensus Estimate by $2 million but fell 2.4% from the year-ago quarter’s figure of $2.1 billion.

The lower-than-expected quarterly earnings of the company were primarily attributable to conflict in the Middle East, which disrupted logistics, delayed deliveries and increased operational costs.

As of March 31, the company had cash and cash equivalents of $1.3 billion and long-term debt of $1.7 billion with a debt-to-capitalization of 21.2%. NOV had $1.5 billion available on its primary revolving credit facility during the same time.

Nabors Industries Ltd. (NBR - Free Report) reported a first-quarter 2026 adjusted loss of $1.54 per share, narrower than the Zacks Consensus Estimate of a loss of $2.39. Additionally, the metric is significantly above the prior-year quarter’s reported loss of $7.5 per share. This outperformance was mainly driven by higher adjusted operating income from its International Drilling segment.

The oil and gas drilling company’s operating revenues of $783.5 million beat the Zacks Consensus Estimate of $779 million. The top line also increased from the year-ago quarter’s $736.2 million, primarily supported by higher contributions from the U.S. Drilling, International Drilling and Drilling Solutions segments.

As of March 31, 2026, Nabors had $500.9 million in cash and short-term investments. Long-term debt was about $2.1 billion, with a debt-to-capitalization of 78.8%.
2026-06-12 16:04 2mo ago
2026-05-08 10:50 4mo ago
Northern Oil and Gas: How I Value This Upstream Operator In 2026
NOG Northern Oil & Gas
FMP Stock News
Original source text
Northern Oil and Gas (NOG) receives a 'Hold' rating with a $16/share price target, citing excessive volatility and complex financials. NOG's non-operator model, heavy hedging, and reliance on M&A introduce significant risks, limiting upside from high oil prices. Despite record production and a high yield, negative GAAP earnings, dilution, and high leverage undermine the investment case.
2026-06-12 16:04 2mo ago
2026-05-08 18:01 4mo ago
Northern Oil and Gas (NOG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
NOG Northern Oil & Gas
FMP Stock News
Original source text
Image: Bigstock

Read MoreHide Full Article

For the quarter ended March 2026, Northern Oil and Gas (NOG - Free Report) reported revenue of $539.86 million, down 6.4% over the same period last year. EPS came in at $0.74, compared to $1.33 in the year-ago quarter.

The reported revenue represents a surprise of +5.57% over the Zacks Consensus Estimate of $511.4 million. With the consensus EPS estimate being $0.71, the EPS surprise was +4.23%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Northern Oil and Gas performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Average Daily Production - Total: 148,303.00 BOE/D versus the five-analyst average estimate of 141,049.30 BOE/D.Average Daily Production - Oil: 73,567.00 BBL/D versus the five-analyst average estimate of 71,669.23 BBL/D.Average Daily Production - Natural Gas and NGLs: 448,444.00 Mcf/D versus 416,720.50 Mcf/D estimated by five analysts on average.Average Sales Prices - Natural Gas and NGLs Net of Settled Natural Gas Derivatives: $2.77 compared to the $3.26 average estimate based on four analysts.Average Sales Prices - Oil Net of Settled Oil Derivatives: $62.00 compared to the $62.19 average estimate based on four analysts.Net Production - Natural Gas and NGLs: 40,360.00 Mcf compared to the 37,818.07 Mcf average estimate based on three analysts.Net Production - Oil: 6,621.00 KBBL versus 6,427.38 KBBL estimated by three analysts on average.Net Production - Total: 13,347.00 KBOE compared to the 12,730.40 KBOE average estimate based on three analysts.Average Sales Prices - Oil: $66.32 versus the two-analyst average estimate of $59.35.Net Sales- Oil and Gas Sales: $539.86 million versus the three-analyst average estimate of $514.84 million. The reported number represents a year-over-year change of -6.4%.Net Sales- Oil Sales: $439.08 million versus the two-analyst average estimate of $375.33 million. The reported number represents a year-over-year change of -4.5%.Net Sales- Natural Gas and NGL Sales: $100.77 million versus the two-analyst average estimate of $122.85 million. The reported number represents a year-over-year change of -14.1%.View all Key Company Metrics for Northern Oil and Gas here>>>

Shares of Northern Oil and Gas have returned -11.7% over the past month versus the Zacks S&P 500 composite's +11% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Zacks' 7 Best Strong Buy Stocks (New Research Report) Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.

Click Here, It's Really Free

Published in earnings earnings-estimates-revisions earnings-surprise
2026-06-12 16:04 2mo ago
2026-05-13 16:30 3mo ago
NOG Declares Quarterly Cash Dividend
NOG Northern Oil & Gas
FMP Stock News
Original source text
MINNEAPOLIS--(BUSINESS WIRE)--Northern Oil and Gas, Inc. (NYSE: NOG) (“NOG” or the “Company”) today announced that its Board of Directors has declared a cash dividend on the Company's common stock. DIVIDEND DECLARATION NOG's Board of Directors has declared a cash dividend in the amount of $0.45 per share, representing an equal amount to the prior quarterly dividend. The dividend is payable on July 31, 2026, to stockholders of record as of the close of business on June 29, 2026. ABOUT NOG NOG is.
2026-06-12 16:04 2mo ago
2026-05-26 06:30 3mo ago
NOG Announces Strategic Entry into Canada with Light Oil Duvernay Acquisition; Takes 25% Undivided Stake in Assets with Long-Term Joint Development Agreement
NOG Northern Oil & Gas
FMP Stock News
Original source text
MINNEAPOLIS--(BUSINESS WIRE)--Northern Oil and Gas, Inc. (NYSE: NOG) (“NOG”) today announced that it has agreed to purchase an undivided 25% interest in the Light-Oil Duvernay Assets owned and operated by Parallax Energy Operating Inc. (“Parallax” or the “Seller”).

MANAGEMENT COMMENTS

"Quality oil inventory is becoming increasingly scarce, and NOG's scaled non-operated model positions us to access opportunities that most in our sector cannot. Our ability to structure creative, accretive transactions with best-in-class operators is what sets NOG apart. The Duvernay is one of North America's premier light oil resources — high-quality, low-cost, long-life inventory with meaningful upside that remains largely untapped. Parallax is led by a team with a demonstrated track record of developing Duvernay assets, backed by Carnelian Energy Capital, one of North America’s leading energy investors. The decision to incorporate equity consideration aligns mutual interests while enhancing our per-share metrics and balance sheet. This transaction is the result of disciplined evaluation of the meaningful opportunities we see in Canada, and a direct reflection of our ability to identify and convert high-quality assets into long-term value for shareholders."

LIGHT-OIL DUVERNAY ACQUISITION

The Assets are comprised of an undivided non-operated interest which includes, net to NOG, ~4,000 Boe per day of production and ~75,000 acres in the Light-Oil Duvernay Shale at an initial unadjusted purchase price of CA$350 million (~US$259 million), subject to typical closing adjustments. The initial unadjusted purchase price will be funded with CA$113 million (~US$83.5) million of NOG common stock issued to the Seller at closing, with the remaining consideration sourced from cash on hand, operating free cash flow and borrowings under NOG’s revolving credit facility.

In addition, NOG has agreed to additional contingent consideration of CA$25 million (~US$18.5 million), payable in cash or common stock (at NOG’s election) in the first quarter of 2028 if certain average oil prices are achieved through the end of 2027.

The acquired Assets include over 500 gross high-quality, low breakeven locations. Substantially all the Assets are operated by Parallax, with NOG participating in development pursuant to a long-term Joint Development Agreement with multi-year drilling commitments entered into in connection with the acquisition.

NOG expects average production for the properties for full year 2027 of ~4,000 Boe per day (2-stream, ~80% oil). Operating costs are expected to be less than $7.50 per Boe/d, below NOG’s corporate average. NOG expects to incur up to US$40 - $45 million in capital expenditures on the assets post-closing in 2026, and US$45 - $50 million in 2027.

In connection with the transaction, NOG intends to enter into derivatives transactions to hedge currency fluctuations related to operating costs on a multi-year basis. Depending on market conditions, NOG may also repurchase a portion of the stock consideration in the open market.

The effective date for the transaction is April 1, 2026, and NOG expects to close the transaction late in the second quarter of 2026. As part of the transaction, NOG has formed a wholly-owned Canadian subsidiary, NOG Energy Canada, Ltd.

ADVISORS

Citigroup Global Markets acted as exclusive advisor to NOG on the transaction. Kirkland & Ellis LLP and Blakes, Cassels & Graydon LLP are serving as Northern’s legal advisors.

National Bank Capital Markets and RBC Capital Markets acted as financial advisors to Parallax on the transaction. Stikeman Elliot LLP served as Parallax's legal advisor.

UPDATED COMPANY GUIDANCE

NOG is providing updated company guidance proforma for the light-oil Duvernay acquisition in line with the “high-end” of the former low activity range; consistent with commentary on our first quarter 2026 earnings call.

Prior FY2026 Low Activity Guidance

Revised FY2026 Annual Guidance

Annual Production (2-stream, Boe/day)

139,000 – 143,000

143,000 – 148,000

Annual Oil Production

68,000 – 72,000

71,500 – 73,500

Net Wells Turned - in- Line (TILs)

68.0 – 72.0

74.0 – 76.0

Total Budgeted Capital Expenditures ($MM)

$850 – $900

$850 – $900

LOE/Production Expenses (per Boe)

$9.65 - $10.10

$9.70 - $9.90

Cash G&A (ex-transaction costs) (per Boe)

$0.81 - $0.86

$0.83 - $0.86

Non-Cash G&A (per Boe)

$0.25 - $0.30

$0.25 - $0.30

Production Taxes (as a % of Oil & Gas Sales)

7% - 8%

7.5% – 8.0%

Oil Differential to NYMEX WTI (per Bbl)

($5.35) – ($6.00)

($5.25 - $5.60)

Gas Realization as a % of Henry Hub/MCF

70% - 75%

70.0% – 72.5%

DD&A Rate per BOE

$15.00 – $16.00

$15.00 - $15.50

Updates to guidance are comprised of:

As described on Q1 call, stand-alone oil production update consistent with “high-end of the low case” from prior guidance Gas volume increase driven by better well performance and timing Minor contribution from pending Duvernay acquisition (late 2Q assumed closing) Capital expenditures, even inclusive of Duvernay transaction, remain unchanged, driven primarily by cost efficiencies LOE guidance updated toward low end of previous guidance Material improvement to oil differentials for the year, driven primarily by Williston pricing Overall gas differentials slightly lower, driven by Waha, mostly offset by Appalachian NGL pricing ABOUT NOG

Northern Oil and Gas (NOG) is the largest publicly traded dedicated non-operator in the United States, built on a differentiated strategy of acquiring non-operated minority working interests and mineral rights across the premier basins of North America. By combining deep industry relationships with disciplined capital allocation, NOG has built a scaled, diversified portfolio that generates durable production and strong cash flow for its shareholders. More information about NOG can be found at www.noginc.com.

ABOUT PARALLAX ENERGY OPERATING INC.

Parallax Energy Operating Inc., an independent oil and natural gas company based in Calgary, Alberta, formed in partnership with funds managed by Carnelian Energy Capital Management, L.P., is focused on leasing, developing and operating oil and gas properties throughout Western Canada. For more information, please visit www.parallaxenergy.ca.

SAFE HARBOR

This press release contains forward-looking statements regarding future events and future results that are subject to the safe harbors created under the Securities Act of 1933 (the “Securities Act”) and the Securities Exchange Act of 1934 (the “Exchange Act”). All statements other than statements of historical facts included in this release regarding NOG’s financial position, common stock dividends, including any increases thereto, business strategy, plans and objectives of management for future operations and industry conditions are forward-looking statements. When used in this release, forward-looking statements are generally accompanied by terms or phrases such as “estimate,” “project,” “predict,” “believe,” “expect,” “continue,” “anticipate,” “target,” “could,” “plan,” “intend,” “seek,” “goal,” “will,” “should,” “may” or other words and similar expressions that convey the uncertainty of future events or outcomes. Items contemplating or making assumptions about actual or potential future sales, market size, collaborations, and trends or operating results also constitute such forward-looking statements.

Forward-looking statements involve inherent risks and uncertainties, and important factors (many of which are beyond NOG’s control) that could cause actual results to differ materially from those set forth in the forward-looking statements, including the following: changes in crude oil and natural gas prices, the pace of drilling and completions activity on NOG’s properties and properties pending acquisition, the effects of the COVID-19 pandemic and related economic slowdown, NOG’s ability to acquire additional development opportunities, changes in NOG’s reserves estimates or the value thereof, general economic or industry conditions, nationally and/or in the communities in which NOG conducts business, changes in the interest rate environment, legislation or regulatory requirements, conditions of the securities markets, NOG’s ability to consummate any pending acquisition transactions (including the transactions described herein), other risks and uncertainties related to the closing of pending acquisition transactions (including the transactions described herein), NOG’s ability to raise or access capital, changes in accounting principles, policies or guidelines, financial or political instability, acts of war or terrorism, and other economic, competitive, governmental, regulatory and technical factors affecting NOG’s operations, products, services and prices.

NOG has based these forward-looking statements on its current expectations and assumptions about future events. While management considers these expectations and assumptions to be reasonable, they are inherently subject to significant business, economic, competitive, regulatory and other risks, contingencies and uncertainties, most of which are difficult to predict and many of which are beyond NOG’s control. NOG does not undertake any duty to update or revise any forward-looking statements, except as may be required by the federal securities laws.

More News From Northern Oil and Gas, Inc.
2026-06-12 16:04 2mo ago
2026-05-28 12:31 3mo ago
Northern Oil and Gas (NOG) Down 23.6% Since Last Earnings Report: Can It Rebound?
NOG Northern Oil & Gas
FMP Stock News
Original source text
It has been about a month since the last earnings report for Northern Oil and Gas (NOG - Free Report) . Shares have lost about 23.6% in that time frame, underperforming the S&P 500.

But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Northern Oil and Gas due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its latest earnings report in order to get a better handle on the important drivers.

Northern Oil Q1 Earnings & Revenues Beat Estimates, Down Y/YNorthern Oil and Gas reported first-quarter 2026 adjusted earnings per share of 74 cents, which beat the Zacks Consensus Estimate of 71 cents. The outperformance reflects strong production. However, the bottom line declined from the year-ago adjusted profit of $1.33 due to weaker natural gas prices and a 77% increase in operating expenses.

The Minnetonka, MN-based oil and gas exploration and production company reported oil and gas sales of $539.9 million, beating the Zacks Consensus Estimate of $511 million, supported by higher crude oil realizations. However, the top line decreased from the year-ago figure of $576.9 million. The year-over-year decline was mainly due to lower oil and gas sales during this quarter.

In February, NOG closed the joint Ohio Utica acquisition of upstream and midstream assets with an adjusted ownership split of 40% for $464.6 million, including the previously paid $58.8 million deposit.

In March, NOG completed a common stock offering of 8.3 million shares of common stock, generating net proceeds of $227.9 million. Funds raised in the offering were applied to the outstanding borrowings on the company’s revolving credit facility.

Q1 Production DetailsThe first-quarter production increased 10% year over year to 148,303 barrels of oil equivalent per day (Boe/d). Additionally, the figure beat our estimate of 141,049 Boe/d.

While oil volume totaled 73,567 Bod (a 6% decrease year over year), natural gas (and natural gas liquids) amounted to 448,444 thousand cubic feet per day (a 33% increase). Our model estimate for oil volume and natural gas production was pegged at 70,000 Bod and 411,400 thousand cubic feet per day, respectively.

The average sales price for crude was $66.32 per barrel, indicating a 2% increase from the prior-year quarter’s level of $64.92. Moreover, the figure beat our expectation of $52.51 per barrel.

The average realized natural gas price was $2.50 per thousand cubic feet compared with $3.86 in the year-earlier period. Our model estimate for the same was pinned at $4.58 per thousand cubic feet.

Costs & ExpensesTotal operating expenses in the quarter rose to $660 million from $372.8 million in the year-ago period. This was mainly on account of a surge in production expenses, general and administrative expenses, impairment of oil and gas assets, and other expenses. The metric came above our estimate of $636.2 million.

Capital ExpendituresThe company reported capital expenditures of $270.1 million for the first quarter, excluding non-budgeted acquisitions and other unplanned items. Of this total, $226.5 million was dedicated to drilling and completion activities on organic assets, while $43.6 million was allocated to Ground Game efforts, including associated development costs.

During the first quarter, NOG placed 17.1 net wells into production.

Financial PositionThe company’s free cash flow for the quarter totaled $30.4 million.

As of March 31, 2026, Northern Oil had $37 million in cash and cash equivalents. The company had a long-term debt of $2.6 billion, with a debt-to-capitalization of 58.8%.

How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in estimates revision.

The consensus estimate has shifted 10.35% due to these changes.

VGM ScoresCurrently, Northern Oil and Gas has a average Growth Score of C, however its Momentum Score is doing a lot better with an A. Following the exact same course, the stock was allocated a score of A on the value side, putting it in the top quintile for value investors.

Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.

OutlookEstimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. Interestingly, Northern Oil and Gas has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
2026-06-12 16:04 2mo ago
2026-05-30 07:03 3mo ago
Northern Oil and Gas: Duvernay Acquisition Comes At A Fair Price, But Adds To Its Leverage
NOG Northern Oil & Gas
FMP Stock News
Original source text
Northern Oil and Gas: Duvernay Acquisition Comes At A Fair Price, But Adds To Its Leverage
2026-06-12 16:04 2mo ago
2026-05-20 10:46 3mo ago
Humana Just Got a Massive Upgrade From Deutsche Bank: Price Target Nearly Doubles to $441
HUM Humana
FMP Stock News
Original source text
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

© wellesenterprises / iStock Editorial via Getty Images

Deutsche Bank just delivered one of the most aggressive analyst upgrades of 2026 on Humana (NYSE:HUM | HUM Price Prediction), lifting the managed care giant to Buy from Hold while nearly doubling its price target to $441 from $235. The move signals that one of Wall Street’s more cautious voices now sees a fundamental reset in the Humana franchise.

Adding to the bullish chorus, Mizuho raised its Humana price target to $335 from $290 and kept an Outperform rating, citing a reduced likelihood of negative medical loss ratio shifts through 2026. For prudent investors weighing a healthcare rebound trade, the upgrade reframes Humana stock as a recovery story rather than a falling knife.

Ticker Company Firm Action Old Rating New Rating Old Target New Target HUM Humana Deutsche Bank Upgrade Hold Buy $235 $441 The Analyst’s Case Deutsche Bank’s thesis rests on a stabilizing managed care market and an expectation that Humana’s Medicare star ratings will recover. Star ratings drive bonus payments, premium positioning, and enrollee plan selection during Annual Election Period shopping.

The firm also frames 2026 as the earnings bottom and a rebasing year, depending on the stars results in October. With Humana having already affirmed FY2026 adjusted EPS of at least $9 against the prior year’s $17.14, the reset narrative has data behind it.

Company Snapshot Humana is a Louisville-based managed care leader anchored by Individual Medicare Advantage, CenterWell Primary Care, and CenterWell Pharmacy Solutions. Q1 2026 results beat on both lines, with adjusted EPS of $10.31 on revenue of $39.65 billion, up 24% year over year.

Individual Medicare Advantage membership climbed 22% year to date, and the insurance segment benefit ratio came in at 89%, slightly favorable to guidance. Humana CEO Jim Rechtin noted, “We’ve had a solid start to the year and feel good about how our operating execution and transformation initiatives are setting us up for the future.”

Why the Move Matters Now HUM stock has staged a sharp comeback, rising 51% over the past month through May 19 and 22% year to date. Deutsche Bank’s upgrade serves as sell-side validation of that rally, particularly given the prior consensus average target of $246.83.

At a P/E ratio of 33x on trailing earnings and a forward P/E ratio of 30x, Humana stock isn’t cheap on near-term numbers. The Deutsche Bank call argues that depressed 2026 earnings normalize materially higher as stars and rates improve.

What It Means for Your Portfolio The bull case is straightforward: star ratings recovery, a friendlier Medicare Advantage rate cycle, completed valuation rebase, and dominant MA exposure that gives Humana upside leverage as conditions improve. The Mizuho raise reinforces that the operating backdrop is stabilizing.

However, the risks remain real. October’s stars results are still a binary catalyst, MA reimbursement remains politically sensitive, and a securities fraud lawsuit tied to Medicare Advantage utilization disclosures was partially allowed to proceed on May 19.

For long-term investors, Humana stock now sits at the intersection of a credible recovery thesis and a stock that has already moved sharply. Sizing positions modestly and watching for whether October’s star ratings confirm the Deutsche Bank thesis could be the more prudent path than chasing the upgrade.
2026-06-12 16:04 2mo ago
2026-05-22 13:30 3mo ago
Congressional Joint Economic Committee Pegs Medicare Advantage Overpayments at $7 Billion Annually and Rising
HUM Humana
FMP Stock News
Original source text
© Rix Pix Photography / Shutterstock.com

According to Kiplinger, the Congressional Joint Economic Committee found Medicare Advantage is overpaying insurers by $212 per enrollee. The figure looks small until you scale it.

The data, scaled Multiply $212 against roughly 33 million Medicare Advantage enrollees and the system is leaking about $7 billion a year in excess payments to private insurers. Medicare Advantage now covers more than half of all Medicare beneficiaries, which puts the overpayment in the middle of the program rather than at its edges.

Where does the $7 billion go? Some flows into insurer margins, helping explain why publicly traded MA carriers rank among the largest U.S. healthcare companies. The rest funds supplemental benefits that drive MA marketing: dental, vision, hearing, gym memberships, and grocery cards traditional Medicare excludes.

The overpayment is structural. It originates in three mechanics: risk adjustment coding incentives that reward plans for documenting more diagnoses, the benchmark methodology CMS uses to set county-level payment rates, and upcoding, where plans capture diagnoses traditional fee-for-service claims would never have generated.

The context Kiplinger does not provide Industry data confirms the pattern. Modern Healthcare reported $33 billion in extra payments to Medicare Advantage plans tied to coding intensity, with UnitedHealth (NYSE:UNH | UNH Price Prediction) and Humana (NYSE:HUM) the primary beneficiaries. CMS has been tightening risk adjustment audits, and several major insurers have faced DOJ investigations over coding practices. A Leerink report indicates UnitedHealth faces the largest RADV audit exposure, with 60 contracts covering 92% of its 2020 Medicare Advantage membership under review.

The political response cuts the other way. CMS announced a 2.48% average increase in Medicare Advantage payments for 2027, sending $13 billion in additional funding to private insurers, well above the 0.09% rate originally proposed in January 2026 that briefly knocked Humana down more than 20%.

How to act on it For a healthy 68-year-old in a mid-cost metro area, the choice between a $0-premium MA plan and traditional Medicare paired with Plan G Medigap and Part D depends on health trajectory and network flexibility.

Moderate use: The $0-premium MA plan typically wins on annual cash outlay. Premiums are nil, primary care copays run low, and dental and vision are bundled. Annual out-of-pocket commonly lands in the low four figures. Major health event: Plan G Medigap caps exposure near the Part B deductible. MA enrollees face prior authorization and a maximum out-of-pocket that often runs $5,000 to $9,000 in-network, with higher exposure out-of-network. Healthy retirees who stay in-network and value the extras tend to come out ahead in MA. Retirees with chronic conditions, frequent travelers, and those who want unrestricted specialist access generally do better with traditional Medicare and Medigap, despite higher monthly premiums.

The takeaway The $212 figure represents the hidden subsidy behind your neighbor’s free dental coverage. As CMS audits tighten and DOJ scrutiny continues, expect supplemental benefits to thin and marketing to soften. If your plan choice hinges on those extras, price the alternative now, before the subsidy that funds them gets reformed.
2026-06-12 16:04 2mo ago
2026-05-27 08:00 3mo ago
Humana completes $83 million Florida infrastructure investment to deepen coordinated patient care approach
HUM Humana
FMP Stock News
Original source text
CenterWell Pharmacy® mail order hub creates jobs, utilizes state-of-the-art equipment to help meet growing demand for reliable medication access

ORLANDO, Fla.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, today announced the start of full operations of its newest CenterWell Pharmacy® mail order distribution center, in Orlando, Florida. The $83 million, state-of-the-art facility bolsters capacity for prescription medication delivery across Florida and the country and reinforces Humana’s longstanding commitment to providing members and patients across the Sunshine State with a simpler, more coordinated care experience.

“This economic investment is testament to both our talent pool and the supportive business environment here in Central Florida,” said U.S. Rep. Darren Soto (FL-09). “The CenterWell distribution center strengthens our local economy. It’s important as well to have health care infrastructure right here in Orlando that supports access to critical medication that people need.”

Enhancing Reliable, Direct Medication Access

CenterWell Pharmacy® serves as a mail-order pharmacy for many Humana members and also provides payer-agnostic fulfillment services, most recently through an emerging line of business involving Direct-to-Consumer (DTC) and Direct-to-Employer (DTE) medication access partnerships.

“This new CenterWell Pharmacy reflects both our excitement for growth and our deep commitment to delivering better outcomes for patients,” said Bethanie Stein, Pharm.D., President of Pharmacy at Humana, including CenterWell Pharmacy®. “As demand continues to grow, we are expanding our capacity with modern, high‑performing pharmacies like Orlando, ensuring more people can access their medications safely, reliably, and in a way that supports long‑term adherence and health.”

Celebrating Job Creation and Enhanced Capabilities

The 162,000 square-foot Orlando distribution center can process and dispense up to 64,000 prescriptions per day. The facility employs more than 165 people – including pharmacists, pharmacy technicians, engineers, and software specialists – with plans to hire more to support pharmacy growth. To mark the site’s full operational status, CenterWell® is holding a ribbon-cutting celebration today, to be attended by local dignitaries.

In addition to industry-leading equipment, the facility also boasts operational efficiencies that streamline the safe handling and delivery of both specialty and traditional medication. Nationwide, CenterWell Pharmacy® boasts a dispensing accuracy rate of 99.9992% and has earned a number of accreditations and awards for customer satisfaction and commitment to patient care. The Orlando location is CenterWell Pharmacy’s third U.S. mail-order facility, with others in Arizona and Ohio.

“This distribution center gives us expanded capacity to meet increased demand for timely, reliable medication access, closing the distance when delivering to patients here in Florida and throughout the southeast United States,” said Guillermo Sollberger, Chief Operating Officer for CenterWell Pharmacy®, which includes specialty and traditional mail-order pharmacy, as well as retail pharmacy locations. “The facility also gives us access to a talented workforce in Greater Orlando, an area known for its specialty pharmacy ecosystem.”

Humana’s Patient-Centered Care Commitment in Florida

Humana serves Floridians through an integrated approach. It is the state’s leading Medicare Advantage provider, with more than 1.1 million Florida members; manages Medicaid benefits for more than 540,000 Floridians through Humana Healthy Horizons®; and serves more than 770,000 military service members, retirees, and their families across the state as a TRICARE provider.

Humana’s CenterWell® care delivery organization in Florida employs more than 6,500 people, who staff more than 200 CenterWell®, Conviva®, and MaxHealth Primary Care locations and nearly 50 CenterWell® and Trilogy Home Health branches, and provide pharmacy services across the state.

“As Florida’s senior population continues to grow, CenterWell’s integrated care model offers improved health and simplified care for those we serve. This critical expansion of pharmacy services deepens our commitment to our patients in Florida and to the entire community, including thousands of local teammates," said Sanjay Shetty, M.D., President of CenterWell®. "We are eager to further our mission to address whole health needs by personalizing care that leads to healthier and more fulfilling lives.”

Workforce Training and Career Opportunities

As part of Humana’s commitment to advancing career opportunities and providing an inclusive environment, CenterWell Pharmacy® invests in training programs and resources for those with no pharmacy experience or those transitioning into the industry. Individuals interested in working at the Orlando distribution center can be trained for pharmacy technician licensing at no charge. Current job openings are listed on the CenterWell Pharmacy careers website.

About Humana

Humana (NYSE:HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell® healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.

About CenterWell

CenterWell® is a leading health care services business focused on creating integrated and differentiated experiences that put our patients at the center of everything we do. The result is high quality health care that is accessible, comprehensive, and, most of all, personalized. As the largest provider of senior-focused primary care, one of the leading providers of home health care, and a leading integrated home delivery, specialty, hospice, and retail pharmacy, CenterWell® is focused on whole health and addressing the physical, emotional and social wellness of our patients. CenterWell® is part of Humana Inc. (NYSE: HUM). Learn more about what we offer at CenterWell.com.

More News From Humana Inc.
2026-06-12 16:04 2mo ago
2026-05-29 12:31 3mo ago
Humana (HUM) Up 30.6% Since Last Earnings Report: Can It Continue?
HUM Humana
FMP Stock News
Original source text
A month has gone by since the last earnings report for Humana (HUM - Free Report) . Shares have added about 30.6% in that time frame, outperforming the S&P 500.

Will the recent positive trend continue leading up to its next earnings release, or is Humana due for a pullback? Well, first let's take a quick look at the most recent earnings report in order to get a better handle on the recent catalysts for Humana Inc. before we dive into how investors and analysts have reacted as of late.

Humana Beats Q1 Earnings Estimates on Increasing Premiums

Humana reported first-quarter 2026 adjusted earnings of $10.31 per share, which beat the Zacks Consensus Estimate by 3.5%. However, the bottom line fell 11% year over year.

Revenues improved 23.5% year over year to $39.6 billion. The top line surpassed the consensus mark by 0.5%.

The quarterly results benefited on the back of premium gains and a robust performance from the CenterWell segment, which saw a revenue jump supported by its primary care business. A rise in overall medical membership also contributed to the upside. However, the upside was partly offset by escalating operating expenses and a deteriorating benefit ratio.

HUM’s Q1 Operational UpdateHumana’s premiums totaled $37.7 billion, which advanced 23.6% year over year, and surpassed the Zacks Consensus Estimate of $37.3 billion and our estimate of $36.6 billion. Services revenues rose 25.7% year over year to $1.7 billion, beating the consensus mark of $1.6 billion. Investment income of $262 million fell 0.8% year over year in the quarter under review. However, the metric beat the consensus mark of $230 million and our estimate of $235.7 million.

The benefit ratio came in at 89.4%, which deteriorated 240 basis points (bps) year over year. Total operating expenses increased 25.9% year over year to $37.9 billion, higher than our estimate of $36.6 billion. The year-over-year increase was due to higher benefits and operating costs. The adjusted operating cost ratio of 10% improved 50 bps year over year.

HUM’s net income declined 4.7% year over year to $1.2 billion but beat our estimate of $1.1 billion.

Q1 Segmental Update of HUMInsuranceThe segment’s revenues rose 23% year over year to $38.1 billion in the first quarter on the back of improved per-member premiums derived from HUM’s Medicare and stand-alone PDP businesses, supported by improved Medicare Advantage benchmark funding from the Centers for Medicare and Medicaid Services and a higher Part D direct subsidy tied to the IRA.

Adjusted operating income dropped 8.8% year over year to $1.4 billion. The benefit ratio deteriorated 200 bps year over year to 89.4%. The operating cost ratio of 7.3% improved 90 bps year over year.

Total medical membership of the segment was 17.7 million as of March 31, 2026, which rose 19.4% year over year. The metric beat the Zacks Consensus Estimate of 16.7 million and our estimate of 15.7 million.

CenterWellThe unit recorded revenues of $6.1 billion in the quarter under review, which improved 19.7% year over year and surpassed the Zacks Consensus Estimate of $5.8 billion. The metric benefited from higher revenues stemming from the company’s primary care business.

Adjusted operating income dropped 25.1% year over year to $338 million. The operating cost ratio of 94.5% deteriorated 340 bps year over year due to the ongoing implementation of the v28 risk model update within the company’s primary care business and higher volumes in CenterWell Specialty Pharmacy.

Humana’s Financial Update (As of March 31, 2026)Humana exited the first quarter with cash and cash equivalents of $5 billion, which rose 17.9% from the 2025-end level. Total assets of $55.3 billion increased 13% from the figure at 2025-end.

Long-term debt amounted to $12.3 billion, down 0.8% from the figure as of Dec. 31, 2025. Debt to capitalization deteriorated 190 bps year over year to 43% at the first-quarter end.

Total stockholders’ equity of $18.6 billion advanced 5.2% from the 2025-end figure.

HUM generated net cash from operations of $1.3 billion in the first quarter of 2026, which increased nearly fourfold year over year.

HUM’s Capital Deployment UpdateHumana bought back shares worth $107 million in the first quarter of 2026. It also paid dividends of $107 million during the same quarter.

2026 View by HUMRevenues are still projected to be a minimum of $160 billion, which implies a 23.4% increase from the 2025 reported figure. The Insurance segment’s revenues are expected to continue to be forecasted at a minimum of $155 billion. Revenues of the CenterWell segment are still expected to be at a minimum of $25 billion.

Adjusted EPS is still projected to be at least $9.00, which indicates a 47.5% decline from the 2025 figure. GAAP EPS is now projected to be at least $8.36, down from the previously expected guidance of at least $8.89.

Management still anticipates Individual Medicare Advantage membership to witness growth of around 25% in 2026. Group Medicare Advantage membership is still expected to record an increase of roughly 150,000.

Membership from the Individual Medicare stand-alone PDP is still expected to increase around 1,000,000 this year. State-based contracts are still anticipated to witness membership growth within 25,000-100,000.

The GAAP benefit ratio for the Insurance segment is still likely to be 92.75%, with a variability margin of plus or minus 25 basis points. The GAAP consolidated adjusted operating cost ratio is still expected to be at 10%, with a variability margin of plus or minus 25 basis points.

GAAP cash flow from operations is still estimated within $2.5-$2.9 billion. Meanwhile, capital expenditures are still projected to be roughly $650 million. The adjusted effective tax rate is expected to be around 25.5%, while the weighted average share count is anticipated at around 121 million.

How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in fresh estimates.

The consensus estimate has shifted 38.73% due to these changes.

VGM ScoresCurrently, Humana has a great Growth Score of A, though it is lagging a lot on the Momentum Score front with a D. However, the stock was allocated a grade of B on the value side, putting it in the second quintile for value investors.

Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.

OutlookEstimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. Interestingly, Humana has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.

Performance of an Industry PlayerHumana is part of the Zacks Medical - HMOs industry. Over the past month, UnitedHealth Group (UNH - Free Report) , a stock from the same industry, has gained 3.3%. The company reported its results for the quarter ended March 2026 more than a month ago.

UnitedHealth reported revenues of $111.72 billion in the last reported quarter, representing a year-over-year change of +2%. EPS of $7.23 for the same period compares with $7.20 a year ago.

UnitedHealth is expected to post earnings of $4.84 per share for the current quarter, representing a year-over-year change of +18.6%. Over the last 30 days, the Zacks Consensus Estimate has changed +0.2%.

The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for UnitedHealth. Also, the stock has a VGM Score of A.
2026-06-12 16:04 2mo ago
2026-05-29 22:00 3mo ago
Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM
HUM Humana
FMP Stock News
Original source text
, /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF continues its investigation into Humana Inc. ("Humana" or "the Company") (NYSE: HUM).

On January 18, 2024, the Company announced its financial results for the fourth quarter and full year 2023, disclosing that its benefits expense ratio increased to approximately 91.4% for the fourth quarter of 2023 and approximately 88% for the full year 2023, resulting in 2023 adjusted EPS of only $26.09 per share, or more than $2 per share less than what the Company had predicted in November 2023. Then, on January 25, 2024, the Company further disclosed a loss for the fourth quarter of 2023 and expected that higher level of medical costs would persist for all of 2024, resulting in expected 2024 adjusted EPS of only $16 per share, a $10 per share decrease from 2023, well below analysts' expectations of $29 per share.

Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period in violation of federal securities laws. Recently, the Court presiding over the case denied the Company's motion to dismiss the case in part, allowing the case to move forward.

KSF's investigation is focusing on whether Humana's officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws. 

If you have information that would assist KSF in its investigation, or have been a long-term holder of Humana shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-833-938-0905 or email KSF Managing Partner Lewis Kahn ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-hum/ to learn more.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, New Jersey, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

SOURCE Kahn Swick & Foti, LLC
2026-06-12 16:04 2mo ago
2026-05-29 23:00 3mo ago
Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM
HUM Humana
FMP Stock News
Original source text
Humana Investigation Continued: Kahn Swick and Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM
2026-06-12 16:04 2mo ago
2026-06-03 11:25 3mo ago
5 HMO Stocks in Focus Amid an Aging U.S. Population, Tech Innovation
HUM Humana
FMP Stock News
Original source text
The U.S. health insurance industry, commonly referred to as the Health Maintenance Organization (HMO), benefits from a set of diversified, cost-effective plans that generate steady premium income and secure contract renewals. However, regulatory changes could tighten Medicaid eligibility and reduce ACA enrollment, affecting membership and reimbursements.  Demand for Medicare products should remain strong as the U.S. population ages, supporting enrollment and premium growth. Investments in telehealth, AI, cloud computing and data analytics are improving efficiency, patient engagement and long-term revenue prospects despite increasing near-term costs. HMOs are also pursuing strategic mergers and acquisitions (M&A) to expand market presence and diversify operations. Industry leaders such as UnitedHealth Group Incorporated (UNH - Free Report) , The Cigna Group (CI - Free Report) , Humana Inc. (HUM - Free Report) , Centene Corporation (CNC - Free Report) and Molina Healthcare, Inc. (MOH - Free Report) are well-positioned to capitalize on these favorable growth dynamics. 

About the Industry The Zacks HMO industry consists of entities (either private or public) that take care of subscribers’ basic and supplemental health services. Players in this space primarily assume risks and assign health and medical insurance policy premiums. Industry participants also provide administrative and managed-care services for self-funded insurance. Services are generally offered via a network of approved care providers (called in-network), which include primary care physicians, clinical facilities, hospitals and specialists. However, out-of-network exceptions are made during emergencies or when medically necessary. Health insurance plans can be availed through private purchases, social insurance or social welfare programs.

4 Trends Shaping the Future of the HMO Industry Diversified Offerings Support Enrolment Stability: Health insurers continue to strengthen their membership base by offering diversified, cost-effective plans with enhanced benefits. These offerings support steady enrollment growth, generate consistent premium income and often lead to contract wins and renewals from federal and state agencies. However, gains from diversified products are expected to only partly offset the expected Medicaid membership declines resulting from growing regulatory challenges following the enactment of the One Big Beautiful Bill Act. The legislation introduced stricter Medicaid eligibility checks, work requirements and reduced federal funding. These measures, coupled with the absence of ACA subsidy extensions, are likely to reduce enrollment and pressure margins, prompting insurers to focus more on higher-margin commercial plans, while anticipated Medicare Advantage reimbursement rate increases in 2026 may provide some support.

An Aging U.S. Population: Medicare plans are specifically designed to meet the healthcare needs of individuals aged 65 and older, and an aging U.S. population is expected to drive sustained demand for these products. As the baby boomer generation enters retirement and life expectancy continues to increase, health insurers are well-positioned to benefit and generate higher premium revenues. To effectively serve this demographic, insurers maintain broad networks of healthcare providers, including physicians, hospitals, pharmacies and ancillary care organizations, while some also operate dedicated senior-focused care centers that deliver personalized, high-quality services tailored to the unique medical and wellness needs of older adults. 

Digital Transformation and Technological Innovation: The HMO industry continues to strengthen its investment in virtual healthcare solutions, or telehealth services, as digital transformation reshapes the healthcare landscape. Technologies such as Artificial Intelligence (AI)-powered chatbots, voice assistants, mobile health applications, robotics, cloud computing and advanced data analytics are revolutionizing the way healthcare services are delivered, allowing patients to receive timely care from the comfort of their homes. This shift not only eases the strain on the U.S. healthcare system by reducing hospital visits and admissions but also enhances patient experience and care accessibility. While the adoption of advanced technologies may initially increase costs for health insurers, the resulting gains are expected to support stronger and more sustainable revenue growth over the long term.

Strategic Expansion Via Mergers and Acquisitions: In addition to embracing technological advancements, HMOs frequently engage in M&A to expand their capabilities, penetrate new markets, strengthen their foothold in existing regions, grow their membership base and enhance their nationwide reach. These strategic transactions also promote business diversification, enabling companies to maintain a competitive edge within the industry. Following the Federal Reserve's three interest rate cuts in 2025, borrowing conditions have become more favorable. Lower financing costs are expected to encourage greater M&A activity. 

Zacks Industry Rank Instills Optimism The group’s Zacks Industry Rank, which is the average of the Zacks Rank of all the member stocks, indicates bright near-term prospects. The Zacks Medical-HMOs industry, which is housed within the broader Zacks Medical sector, currently carries a Zacks Industry Rank #27, which places it in the top 11% of 246 Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than two to one. 

The industry’s positioning in the top 50% of the Zacks-ranked industries is a result of a positive earnings outlook for the constituent companies in aggregate. 

Before we present a few stocks that you may want to buy or retain in your portfolio, let’s look at the industry’s recent stock-market performance and valuation picture.
 

Industry Underperforms S&P 500, Outperforms Sector The Zacks Medical-HMO industry has gained 17.3% in the past year compared with the Zacks S&P 500 composite’s 31.3% growth. The Zacks Medical sector rallied 2.8% in the same time frame. 

One-Year Price Performance
 
Image Source: Zacks Investment Research

Industry's Current Valuation Based on the forward 12-month price-to-earnings (P/E) ratio, which is commonly used for valuing medical stocks, the industry trades at 16.66X compared with the S&P 500’s 22.17X and the sector’s 19.33X. 

Over the past five years, the industry has traded as high as 19.57X and as low as 11.58X, with the median being at 16.14X, as the chart below shows.

Forward 12-Month Price/Earnings (P/E) Ratio
Image Source: Zacks Investment Research

Image Source: Zacks Investment Research

5 Stocks to Keep a Close Eye On We present five stocks from the space, either carrying a Zacks Rank #2 (Buy) or #3 (Hold). Considering the current industry scenario, it might be prudent for investors to buy or retain these stocks in their portfolio, as these are well-placed to generate growth in the long haul. 

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Centene: Based in Missouri, Centene continues to benefit from strong momentum in its Medicare and Medicaid businesses, supported by numerous contract awards and steady membership expansion. The growing aging population in the United States remains a key driver of demand for Medicare Advantage plans, reinforcing the strength of Centene’s Medicare segment. This Zacks Rank #1 company also pursues strategic growth through acquisitions and provider partnerships. Management projects premium and service revenues within $171-$175 billion for 2026.

The Zacks Consensus Estimate for Centene’s 2026 earnings is pegged at $3.47 per share, which indicates a 66.8% rise from the year-ago figure. CNC’s earnings outpaced estimates in three of the last four quarters and missed the mark once, the average being 74.90%.

Price & Consensus: CNC
Image Source: Zacks Investment Research

Molina Healthcare: This California-based health insurer develops affordable Medicare and Medicaid plans, enriched with extensive benefits, which have consistently led to contract wins. These contracts have contributed to a steadily growing customer base for the Zacks Rank #2 company. Management expects the 2026 premium revenue outlook to be approximately $42 billion. The company continues to strengthen its market position through acquisitions, including ConnectiCare in 2025. 

The Zacks Consensus Estimate for Molina Healthcare’s 2026 earnings is pegged at $5.23 per share. The consensus mark for MOH’s 2026 earnings has moved 0.4% north over the past 30 days.  MOH’s earnings beat estimates in one of the last four quarters and missed the mark thrice. 

Price & Consensus: MOH
Image Source: Zacks Investment Research

UnitedHealth Group: Minnesota-based UnitedHealth Group continues to deliver solid revenue growth, driven by the strong performance of its UnitedHealthcare and Optum segments. UnitedHealthcare benefits from enhanced Medicare and Medicaid offerings that combine affordability with attractive benefits. Optum remains a key growth engine, leveraging strategic acquisitions, advanced technology and data-driven healthcare solutions to enhance care delivery and operational efficiency. Additionally, continued focus on mergers and acquisitions, coupled with expanding telehealth capabilities, strengthens the nationwide footprint of this Zacks Rank #3 company. 

The Zacks Consensus Estimate for UnitedHealth Group’s 2026 earnings is pegged at $18.29 per share, which implies 11.9% growth from the year-ago figure. UNH’s earnings beat estimates in three of the last four quarters and missed the mark once, the average surprise being 0.84%. 

Price & Consensus: UNH
Image Source: Zacks Investment Research

Cigna: Based in Connecticut, the company continues to demonstrate strong growth, supported by the robust performance of its two key business segments—Evernorth and Cigna Healthcare. Evernorth benefits from its comprehensive portfolio of specialty pharmacy services, while Cigna Healthcare leverages its broad customer base across both the U.S. Government and U.S. Commercial markets. This Zacks Rank #3 company further enhances its market position and growth prospects through strategic acquisitions and partnerships with leading healthcare organizations, while continuously expanding its product offerings.

The Zacks Consensus Estimate for Cigna’s 2026 earnings is pegged at $30.38 per share, indicating 1.8% growth from the prior-year figure. CI’s earnings beat estimates in each of the last four quarters, the average surprise being 1.86%.

Price & Consensus: CI
Image Source: Zacks Investment Research

Humana: Headquartered in Kentucky, Humana has delivered steady growth, driven by increasing premium income and a strong membership base across its Medicare and Medicaid segments. The strong execution of these programs has enabled this Zacks Rank #3 company to win new contracts and successfully renew existing agreements with federal and state government agencies. Through its CenterWell platform, Humana continues to focus on meeting the evolving healthcare needs of the nation’s growing senior population. Additionally, strategic acquisitions such as Family Physicians Group, iCare and Inclusa have strengthened the company’s business diversification efforts and expanded its geographic reach.  

The Zacks Consensus Estimate for Humana’s 2026 earnings is pegged at $9.01 per share. The consensus mark for 2025 revenues implies 25.3% growth from the year-ago actual. HUM’s earnings surpassed estimates in three of the last four quarters and missed the mark once, the average surprise being 3.80%. 

Price & Consensus: HUM
Image Source: Zacks Investment Research
2026-06-12 16:04 2mo ago
2026-06-04 13:32 3mo ago
Humana Jumps 6%, UnitedHealth Climbs 5%, Cigna Rises 4% as Analysts Cheer Softer Medical Cost Trends
HUM Humana
FMP Stock News
Original source text
Health insurers are running higher in Thursday afternoon trading after a wave of bullish Wall Street analyst notes on the managed-care sector, centered on UnitedHealth, citing softer medical cost and utilization trends plus potential AI efficiency upside. Humana (NYSE:HUM | HUM Price Prediction) stock is leading the move, up 6% to $348, with UnitedHealth Group (NYSE:UNH) stock up 5% to $396 and Cigna (NYSE:CI) stock up 4% to $282.

The catalyst is a fresh cluster of analyst actions framing managed care as a margin-recovery story. The thesis: utilization is moderating, medical loss ratios are improving, and artificial intelligence could unlock meaningful efficiency gains across the group.

Healthcare more broadly is participating. The Health Care Select Sector SPDR Fund (NYSEARCA:XLV) is up 3% on the session, signaling the rally is concentrated in managed care but spilling into adjacent groups.

Analyst Upgrades Center on UnitedHealth [stock_chart symbol=”NYSE:UNH”]

Morgan Stanley’s Erin Wright raised UnitedHealth’s price target to $453 from $395 and maintained an Overweight rating. Wright noted that managed care stocks have been “grinding higher” on emerging signs of softer utilization trends, and estimated that AI-driven efficiencies could deliver 45% average earnings-per-share upside for managed care organizations as efficiency scales.

Bank of America analyst Kevin Fischbeck upgraded UnitedHealth stock to Buy from Neutral and raised his price target to $450 from $420, citing improving medical cost trends and a favorable Q2 2026 earnings setup. Fischbeck stated that UnitedHealth should lead a broader rally of managed care organizations if utilization trends continue to moderate.

Truist raised its UnitedHealth share-price target to $440 from $395 and kept a Buy rating, citing favorable Q1 medical cost trends versus consensus and embedded earnings potential tied to margin recovery in the government businesses. A separate Morgan Stanley note framed UnitedHealth, CVS Health (NYSE:CVS), and Cigna as managed-care companies that could benefit from utilization trends and AI upside.

Sector-Wide Lift Pulls Peers Along The optimism is reaching beyond UnitedHealth. CVS Health is benefiting from the same softer-cost narrative, with its Q1 2026 medical benefit ratio improving to 85% from 87% and Health Care Benefits adjusted operating income surging 53% to $3.04 billion.

Humana’s recent strength stands out among the three names. Humana stock is up 37% over the past month and 28% year-to-date, supported by Q1 2026 results showing an insurance segment benefit ratio of 89% and medical and pharmacy cost trends slightly better than expectations across new and existing membership.

However, Cigna is a different story. The stock is down 2% year-to-date and down 10% over the past year, so today’s bid is more of a recovery bounce than a continuation. Cigna’s Q1 2026 medical care ratio still improved to 80% from 82% prior year, and management raised its full-year 2026 adjusted income from operations outlook to at least $30.35 per share.

UnitedHealth’s Supporting Signals UnitedHealth has additional tailwinds beyond the analyst notes. On June 3, UnitedHealth’s board authorized a dividend of $2.32 per share, payable June 23. The company’s Q1 2026 revenue came in at $111.7 billion, with adjusted earnings of $7.23 per share, surpassing the $6.61 estimate.

The medical cost ratio (MCR) improvement is the centerpiece. UnitedHealth’s MCR improved 90 basis points to 84%, a meaningful inflection after a difficult 2025. According to Koyfin data cited in reporting, 22 of 28 analysts rate UnitedHealth stock as a Buy or higher, five rate it as a Hold, and one rates it as a Sell.

Retail sentiment is firming up, as well. Sentiment surrounding UNH stock on Stocktwits improved to neutral from bearish over the prior 24 hours, consistent with the bid showing up in the tape today.

What to Watch Now The key question is whether utilization trends keep moderating into the second quarter. The Q2 2026 earnings setup that Bank of America flagged could be the next major test for the thesis, and investors can size their positions accordingly while the data evolves.

For Humana shareholders, the question is whether the month-long run can hold after such a strong move. Meanwhile, for Cigna shareholders, today’s bounce may signal the start of mean reversion, but the year-to-date laggard status means traders may stay selective until momentum builds.

The UnitedHealth dividend will be paid on June 23, giving income-focused holders a near-term catalyst. Watch for whether the broader managed-care rally has legs, or whether today’s lift fades into the close as profit-takers trim their exposure.
2026-06-12 16:04 2mo ago
2026-06-04 17:43 3mo ago
Humana Inc (HUM) Shares Surge 6.8% -- What GF Score of 86 Tells Investors
HUM Humana
FMP Stock News
Original source text
On June 04, 2026, Humana Inc (HUM) shares rose 6.8% to a current price of $349.80. The stock has seen significant price performance recently, with a 52-week ran
2026-06-12 16:04 2mo ago
2026-06-05 15:50 3mo ago
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?
HUM Humana
FMP Stock News
Original source text
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Shareholders should contact the firm immediately as there may be limited time to enforce your rights. 

, /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Humana Inc. (NYSE: HUM) breached their fiduciary duties to shareholders.

If you currently own Humana stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved financial incentive award, or other relief and benefits. Please click here to learn more about your legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].

Why Your Participation Matters:

Shareholder involvement can help improve a company's policies, practices, and oversight mechanisms to create a more transparent, accountable, and effectively managed organization, which can enhance shareholder value.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
One World Trade Center
85th Floor
New York, NY 10007
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com

SOURCE Halper Sadeh LLP
2026-06-12 16:04 2mo ago
2026-06-05 16:00 3mo ago
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?
HUM Humana
FMP Stock News
Original source text
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, June 5, 2026
2026-06-12 16:04 2mo ago
2026-06-07 08:25 3mo ago
Medicare Advantage Continues To Grow Despite Health Insurer Exits
HUM Humana
FMP Stock News
Original source text
A KFF report showed 55% of eligible Medicare beneficiaries are enrolled in privatized Medicare Advantage this year, "though the pace of enrollment growth continued to slow." The report was issued June 5, 2026

getty

Despite some high-profile retreats by health insurers from Medicare Advantage, the privatized medical coverage for older adults continues to add health plan members and is now the choice of 55% of eligible beneficiaries, a new report shows.

Medicare Advantage plans contract with the federal government to provide coverage available in traditional Medicare plus extra benefits and services to seniors, such as disease management, drug coverage and nurse help hotlines with some also offering vision, dental care and wellness programs.

“While a growing share of Medicare beneficiaries are enrolled in a Medicare Advantage plan, the pace of the increase in enrollment continued to slow in 2026,” a new analysis by KFF shows.

The KFF analysis is an indication that Medicare Advantage remains popular among old adults and those who may have been forced to choose a new plan because their insurer left the market continued with such coverage at another company. Health insurers that are the biggest players in privatized Medicare Advantage coverage including UnitedHealth Group’s UnitedHealthcare and CVS Health’s Aetna health insurance business have pulled back for this year after years expanding their geographic footprints.

But the KFF report indicated the large companies still have the biggest market share of Medicare Advantage.

“Medicare Advantage enrollment is highly concentrated among plans owned by a small number of parent organizations, with UnitedHealth Group leading the market, and, together with Humana, accounting for nearly half (46%) of all Medicare Advantage enrollees nationwide, the same as in 2025, and consistent with the pattern in prior years,” the KFF report showed.

“However, market shares for the leading parent organizations changed with UnitedHealth Group dropping to 26% (down from 29%), and Humana increasing to 20% (up from 17%),” KFF said. “In absolute numbers, Humana had the largest growth in enrollment, with 1.3 million more enrollees in 2026 than in 2025. In contrast, enrollment in UnitedHealth Group plans decreased by nearly 647,000 from 2025 to 2026.”

MORE FOR YOU

After two years of grappling with rising costs of seniors with a pent-up demand for healthcare services, health plans reevaluated the markets they have been in historically, including some that are unprofitable, and announced last fall that they are retreating to markets where they have adequate doctor and hospital networks to offer rich benefit packages at competitive prices.

Wall Street analysts and investors have been worried about whether these plans could manage their costs after promising first quarter financial results. So far, the companies are indicating that Medicare Advantage cost trends are easing from the last two years.

Humana, for example, last week reaffirmed its 2026 full-year adjusted earnings per share guidance of at least $9. And UnitedHealth and CVS stocks rallied last week along with other health insurers in part after analysts “highlighted moderating health care utilization trends,” Investors Business Daily said in a report.
2026-06-12 16:04 2mo ago
2026-06-09 18:06 3mo ago
As Tech Stocks Slide, The Healthcare Sector Shines. Why Some Experts Say They Like This Defensive Play
HUM Humana
FMP Stock News
Original source text
Key Takeaways Healthcare stocks have outperformed the broader market over the past week, as investors rotated out of tech and into more defensive plays.Analysts at UBS and SentimenTrader suggested they see more gains ahead for the sector, which has underperformed the broader market in 2026 so far. Tech stocks are pulling back, and healthcare is surging.

The S&P 500's health care sector climbed over 1% Tuesday while the broader index lost ground, weighed down by a sell-off in tech shares. Over the past five sessions, healthcare was the best-performing sector, up close to 6%, while the broader index slipped about 3%. Major insurers such as Humana (HUM) and UnitedHealth Group (UNH) have been some of the biggest gainers during that time, with Humana shares up 13% and UnitedHealth adding about 10% over the past week amid anticipation of improving cost trends. Medical device makers such as Medtronic (MDT) and drugmakers like Eli Lilly (LLY) have also gained, with their shares up around 11% and 8%, respectively.

Why This Matters to Investors Healthcare stocks have long been seen as defensive plays, as medical products and services are often viewed as less sensitive to economic downturns, and may outperform other sectors in a risk-off environment.

The recent momentum highlights the sector's value as a defensive play, UBS analysts wrote Tuesday. The sector has outperformed the S&P 500 on 85% of the days when the benchmark was down 1% or more, the analysts said; between Wednesday and Friday, it outperformed tech by the widest margin over three trading days since 2002, according to Bespoke. (It has, however, lagged the broader market year-to-date: The healthcare sector is little changed for 2026, compared to the broader S&P 500's roughly 8% gain. Read Investopedia's full coverage of today's trading here.)

Expectations of growth tied to booming demand for weight-loss drugs and falling costs related to AI's use in drug discovery, along with demographic shifts that could raise healthcare needs, "underpins our positive outlook on the sector," UBS wrote.

SentimentTrader analyst Jay Kaeppel, who wrote in a report Monday that healthcare has "rarely performed worse relative to the S&P 500 Index," suggested its weak showing year-to-date could mean more gains ahead, making the present an "excellent buying opportunity."

"Its time to put Healthcare back on the radar," he wrote.
2026-06-12 16:04 2mo ago
2026-06-10 08:34 3mo ago
Trump's Economy Hired Nearly 1 Million Healthcare Workers While Every Other Sector Lost Jobs. Here's Where to Put Your Money
HUM Humana
FMP Stock News
Original source text
© 24/7 Wall St // Sean Gallup / Getty Images News via Getty Images

Economist Justin Wolfers dropped a number on the Prof G Markets podcast that should reorganize how you think about the 2026 economy. Since Trump took office, healthcare and social services has added roughly 901,000 jobs, while every other part of the economy has actually lost jobs on net. One sector hiring. Everything else shedding.

Before we mortgage the house on hospital REITs, Wolfers offered an honest caveat. He warned the finding may be “somewhat less relevant than it sounds” because overall job creation is naturally low thanks to weak population growth: “The closer you are to the whole not growing very much, the more likely it is you’ll end up in a world in which one sector’s doing all the positive and everything else is a negative.” In other words, slow-growth arithmetic flatters whichever sector happens to be expanding.

Still, the labor data is real. Total nonfarm payrolls reached 159,001 thousand in May 2026, with unemployment steady at 4.3%. I have been reading every jobs report for the better part of a decade, and the divergence between healthcare and everything else is the most lopsided I can remember outside of a recession.

Why Wall Street Hated the News

Wolfers explained the paradox simply: investors are playing “the game of Federal Reserve.” Strong jobs mean the Fed has no reason to rescue the labor market with rate cuts, while core PCE keeps grinding higher (the index hit 129.63 in April). Polymarket now prices zero rate cuts in 2026 at roughly 80% probability, with the funds rate parked at 3.75% since January and the 10-year Treasury at 4.56%.

That means we’ll likely continue a cycle of more job growth in healthcare while rates remain elevated. This impacts two primary sectors.

Where the Hiring Is Showing Up in Stocks UnitedHealth Group (NYSE:UNH | UNH Price Prediction) just posted Q1 2026 adjusted EPS of $7.23 against a $6.61 estimate, with the medical cost ratio tightening 90 basis points to 83.9%. The stock is up 26% year to date.

Humana (NYSE:HUM) is the comeback story, up 42% YTD despite a brutal Star Ratings headwind that crushed FY2026 adjusted EPS guidance to at least $9.00 from $17.14 in 2025. Individual Medicare Advantage membership is up roughly 22% year to date. CVS Health (NYSE:CVS) raised FY2026 adjusted EPS guidance to $7.30 to $7.50 after Aetna’s medical benefit ratio improved to 84.6% from 87.3%.

The Other Side: Rates Stay High With Financial Tailwinds JPMorgan Chase (NYSE:JPM) just reported Q1 2026 net income of $16.49 billion with markets revenue at a record $11.60 billion. Jamie Dimon called the economy “resilient” while flagging risks ranging from trade uncertainty to elevated asset prices.

Realty Income (NYSE:O) is up 11% YTD and yields over 5%, with Q1 AFFO per share growing 6.6% and investment volume guidance raised to $9.5 billion at 7.1% cash yields. Sumit Roy is deploying capital as if rates will stay where they are, which Polymarket says is the right bet.

The Frame for Your Portfolio Wolfers’ caveat matters, but the investing implication holds either way. If you believe the labor market keeps printing healthcare jobs while the Fed stays parked, the defensive sleeve with real demand (the insurers and pharmacy chains serving an aging population) makes sense, the bank earning a fat net interest margin makes sense, and a net-lease REIT that already underwrote 7%+ yields makes sense. The next signal to watch is the June 16 to 17 FOMC meeting and the next core PCE report. If inflation reaccelerates, the conversation shifts from “no cuts” to “possible hikes,” and the math on every dividend stock changes overnight.
2026-06-12 16:04 2mo ago
2026-06-10 09:00 3mo ago
Humana and CenterWell Employees Donate More Than $1.4 Million in 24 Hours
HUM Humana
FMP Stock News
Original source text
-

Humana Foundation’s Annual Double Match Day raises funds and surprises three lucky employees with a total of $45,000 in grants for nonprofits

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana and CenterWell employees combined to donate more than $1.4 million to nonprofit organizations in just 24 hours during the Humana Foundation’s annual Double Match Day in April. During the event, more than 1,600 employees donated to a total of 1,650 nonprofits across the United States to support their communities.

Since 2022, Humana and the Humana Foundation have contributed a combined $5.9 million in matching donations during Double Match Day.

“Our employees consistently show up for the communities they call home, and Double Match Day is a powerful example of that commitment,” said Jim Rechtin, president and CEO of Humana. “The generosity of Humana and CenterWell teammates reflects our shared purpose and their commitment to making a real difference in people’s lives.”

Double Match Day is the signature initiative for the Humana Foundation’s yearlong matching donations program. Throughout the year, employees can maximize charitable gifts to their communities through a one-to-one match by the Humana Foundation. However, on Double Match Day, the Humana Foundation doubles the impact during a 24-hour span to offer two-to-one matching of employee donations. The result is one of the most impactful days of giving to our employees.

“Double Match Day is a reminder of what’s possible when our teammates rally around the causes they care about,” said Humana Foundation CEO, Tiffany Benjamin. “The event reflects the heart of our culture and highlights how we show up for each other and the communities we serve.”

Throughout Double Match Day, employees shared personal stories about the nonprofits they supported using the hashtag #GotMyMatch. From health and housing to education and food security, employees supported causes close to their hearts.

“I #GotMyMatch to Feeding America for my mom who was a tireless food bank volunteer,” wrote April Williams, an associate director for enterprise data governance with Humana. “When my mom finished at the food bank, she also visited neighborhoods in Washington, DC, and gave out as much of the remaining food as she could spare.”

The Humana Foundation also awarded $45,000 via three separate grants to employees who participated in Double Match Day. The grant recipients – one $25,000 winner and two $10,000 winners – then selected their favorite nonprofit to receive the funds.

For more information about the Humana Employee Matching Gift Program and community impact initiatives, visit Humana Foundation | Investing in Humana Employees.

About the Humana Foundation

The Humana Foundation was established in 1981 as the philanthropic arm of Humana Inc. and is focused on health equity, working to eliminate unjust, avoidable, and unnecessary barriers in health and healthcare. The Foundation fosters evidence-based collaborations and investments that help people in underserved communities live connected, healthy lives. As a steward of good health, the Foundation creates healthy emotional connections for people and communities and is shaping a healthier approach to nutrition to support lifelong well-being. For more information, visit humanafoundation.org.

More News From Humana Inc.

Back to Newsroom
2026-06-12 16:04 2mo ago
2026-06-10 16:30 3mo ago
Humana Announces Agreement to Divest Minority Interest in Gentiva
HUM Humana
FMP Stock News
Original source text
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced that it has signed a definitive agreement with a consortium of investors to divest all or substantially all of its minority interest in Gentiva, the nation's leading provider of end-of-life services, including hospice and palliative care. The agreement values Humana's minority interest stake at approximately $900 million. Other financial terms were not disclosed. Humana intends to utilize proceeds from the sale for genera.
2026-06-12 16:04 2mo ago
2026-06-10 16:53 3mo ago
Humana divests minority stake in hospice provider Gentiva
HUM Humana
FMP Stock News
Original source text
Humana said on Wednesday it has agreed to sell all or ​substantially all of its minority stake ‌in Gentiva, a provider of hospice and palliative care services, in a deal valuing the ​stake at about $900 million.
2026-06-12 16:04 2mo ago
2026-06-10 18:30 3mo ago
Humana To Divest End-Of-Life Care Business For $900 Million
HUM Humana
FMP Stock News
Original source text
Humana Wednesday said it has signed a “definitive agreement with a consortium of investors to divest all or substantially all of its minority interest in Gentiva, the nation’s leading provider of end-of-life services, including hospice and palliative care.” In this photo is Humana Inc. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Wednesday, July 30, 2025. Photographer: Michael Nagle/Bloomberg

© 2025 Bloomberg Finance LP

Humana, one of the nation’s largest providers of privatized Medicare Advantage health insurance for older adults, announced plans to divest its minority stake in a provider of end-of-life services for $900 million.

Humana Wednesday said it has signed a “definitive agreement with a consortium of investors to divest all or substantially all of its minority interest in Gentiva, the nation’s leading provider of end-of-life services, including hospice and palliative care.”

Humana said the company “intends to utilize proceeds from the sale for general corporate purposes.” The deal is expected to close in the third quarter of this year subject to various regulatory approvals.

Humana said the divestiture of Gentiva continues a process it began several years ago even before Jim Rechtin took over as chief executive of the insurer to sell off various “non-core” Kindred At Home businesses "including hospice, palliative, and personal health care services.

“In 2022, Humana announced an agreement to divest a majority interest in the Hospice and Personal Care divisions of Humana’s Kindred at Home subsidiary (KAH Hospice) to private investment firm Clayton, Dubilier & Rice,” Humana said in a statement. “These divisions were then subsequently restructured into a standalone business and rebranded to Gentiva, which is now the nation’s largest end-of-life care provider, with thousands of compassionate clinicians and caregivers providing services at more than 430 locations in 35 states.”

MORE FOR YOU

Though Humana is best known for its health insurance business, covering more than 6 million older adults in its Medicare Advantage plans, the company is investing heavily under Rechtin in its CenterWell healthcare services business that includes pharmacy, specialty pharmacy and related distribution. CenterWell contributed more than $22 billion in revenue to Humana’s total sales last year of $129.6 billion, according to the insurer’s most recent financial report.

Under Rechtin, the CenterWell business has been more focused on higher growth areas including specialty pharmacy and pharmacy. Earlier this year, for example, Mark Cuban’s Cost Plus Drug Company and Humana’s CenterWell Pharmacy confirmed they have formed a partnership “to develop new end-to-end employer prescription solutions.”
2026-06-12 16:04 2mo ago
2026-06-11 14:21 3mo ago
Humana Closes the Kindred Chapter With $900 Million Gentiva Exit
HUM Humana
FMP Stock News
Original source text
Key Takeaways Humana will receive roughly $900 million from the sale of its remaining Gentiva stake.The deal completes HUM's exit from hospice and personal care assets tied to Kindred.Management expects no material impact on 2026 earnings from the divestiture. Humana Inc. (HUM - Free Report) recently agreed to sell all, or substantially all, of its remaining minority stake in Gentiva, the hospice and palliative care company that emerged from the restructuring of Kindred at Home’s hospice and personal care operations. The transaction values Humana’s stake at roughly $900 million and is expected to close in the third quarter of 2026.

The move completes a strategy Humana set in motion after acquiring Kindred at Home in 2021 and later spinning off non-core hospice and personal care assets. Gentiva has since grown into one of the largest end-of-life care providers in the United States. It operates at more than 430 locations across 35 states and employs over thousands of caregivers and associates.

The minority stake sale to a consortium of investors marks the final step in Humana’s multiyear effort to exit ownership of businesses outside its core health insurance and home-health strategy. It simplifies the company’s portfolio, unlocks capital from a mature investment, and sharpens management’s focus on areas where Humana sees stronger long-term strategic value.

Management said the cash will be used for general corporate purposes. Importantly, Humana does not expect the divestiture to have a material impact on its 2026 earnings, suggesting the Gentiva stake was not a major contributor to current profitability. Gentiva Hospice generated revenues of $2.1 billion in 2025, which led to a net loss of $84 million.

HUM’s Price PerformanceHumana’s shares have gained 42.3% year to date compared with the 24.7% rise of the industry it belongs to.

Image Source: Zacks Investment Research

Zacks Rank & Stocks to ConsiderHumana currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the broader Medical space are Biodesix, Inc. (BDSX - Free Report) , Molina Healthcare, Inc. (MOH - Free Report) and Pediatrix Medical Group, Inc. (MD - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Zacks Consensus Estimate for Biodesix’s full-year 2026 earnings implies a 36% improvement from the year-ago reported figure. It has remained stable over the past 30 days. Over the last four quarters, BDSX beat earnings estimates thrice and missed once, with an average surprise of 25.6%.

The consensus estimate for Molina Healthcare’s 2026 full-year earnings is pegged at $5.23 per share, which has witnessed five upward estimate revisions over the past 60 days against no downward movement. The consensus mark for MOH’s current-year revenues is pegged at $44.07 billion.

The Zacks Consensus Estimate for Pediatrix Medical’s 2026 bottom line suggests 9.3% year-over-year growth. MD has witnessed three upward estimate revisions over the past 60 days against no movement in the opposite direction. It beat earnings estimates in three of the last four quarters and missed once, with an average surprise of 21.3%.
2026-06-12 16:04 2mo ago
2026-06-12 07:36 2mo ago
First Look: SpaceX Launches Largest-Ever IPO; Oracle Tumbles, ECB Hikes Rates
HUM Humana
FMP Stock News
Original source text
Stock News SpaceX debuts with record IPO: SpaceX (SPCX) began trading on the Nasdaq at $135 per share, raising $75 billion in the largest IPO in history and val
2026-06-12 16:04 2mo ago
2026-04-27 13:15 4mo ago
Delek Gears Up to Report Q1 Earnings: Key Metrics to Watch
DK Delek US Energy
FMP Stock News
Original source text
Key Takeaways DK to post Q1 results on April 29, with estimates pointing to a loss of $1.52 per share on $2.1B in revenues.Refining revenues are expected to drop sharply due to Big Spring's turnaround and reduced throughput levels.Cost pressures from higher expenses and interest may hurt margins, though optimization efforts offer support. Delek US Holdings, Inc. (DK - Free Report) is set to release first-quarter 2026 results on April 29. The Zacks Consensus Estimate for the to-be-reported quarter is pegged at a loss of $1.52 per share on revenues of $2.1 billion.

Let us delve into the factors that might have influenced DK’s performance in the to-be-reported quarter. Before that, it is worth taking a look at the company’s performance in the last reported quarter.

Highlights of Q4 Earnings & Surprise HistoryIn the last reported quarter, the Brentwood, TN-based oil and gas refining and marketing company’s adjusted earnings beat the consensus mark. DK reported adjusted earnings of 44 cents per share, which was a cent higher than the Zacks Consensus Estimate, supported by stronger year-over-year performance across both segments and a 12.2% reduction in total costs. Net revenues of $2.4 billion beat the Zacks Consensus Estimate by 6.3%.

DK’s earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed the remaining one, delivering an average surprise of 189%.

This is depicted in the graph below:

DK Stock’s Trend in Estimate RevisionThe Zacks Consensus Estimate for first-quarter 2026 earnings has been revised downward by 22.6% in the past seven days. The estimated figure indicates 34.5% year-over-year growth. However, the Zacks Consensus Estimate for revenues indicates a decline of about 21.2% from the year-ago period’s actual.

Factors to Consider Ahead of DK’s Q1 ReleaseDK's total revenues are expected to have suffered in the quarter to be reported. The company is an independent refiner, transporter and marketer of petroleum products, with its operations organized into two reportable segments: Refining and Logistics.

The Zacks Consensus Estimate predicts first-quarter revenues to decrease from the year-ago quarter’s $2.6 billion. Our model predicts that revenues from the Refining segment will generate revenues of $1,817.6 million, down from $2,608.3 million in the year-ago period. Moreover, the company predicts that a planned turnaround at the Big Spring refinery is expected to significantly reduce throughput, weighing on refining margins and overall system utilization. Operating expenses are projected to rise due to preparations for winter storm disruptions, while interest costs remain elevated, further squeezing profitability.

On the bullish side, Delek could outperform expectations driven by the strong execution of its enterprise optimization plan, which is delivering meaningful cost savings and margin improvements across segments. Continued strength in logistics and wholesale marketing, along with improved margin capture and product optimization, may offset refinery downtime.

What Does Our Model Say About DK Stock?Our proven model does not conclusively predict an earnings beat for Delek this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But this is not the case here.

DK’s Earnings ESP: Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, for this company is -2.30%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

DK’s Zacks Rank: DK currently carries a Zacks Rank #3.

Stocks With the Favorable Combination

Here are some firms from the energy space that you may want to consider, as these have the right combination of elements to post an earnings beat this reporting cycle.

ConocoPhillips (COP - Free Report) has an Earnings ESP of +8.05% and a Zacks Rank #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

COP is scheduled to release earnings on April 30. Notably, the Zacks Consensus Estimate for 2026 earnings indicates 18.5% year-over-year growth. Valued at around $148.4 billion, COP’s shares have gained 31% in a year.

Valero Energy Corporation (VLO - Free Report) has an Earnings ESP of +3.23% and a Zacks Rank #1 at present. It is scheduled to release earnings on April 30.

The Zacks Consensus Estimate for VLO’s 2026 earnings indicates 79.4% year-over-year growth. Valued at around $70.5 billion, VLO’s shares have surged 105.5% in a year.

Diamondback Energy, Inc. (FANG - Free Report) has an Earnings ESP of +0.64% and a Zacks Rank #2 at present. It is slated to release earnings on May 04.

The Zacks Consensus Estimate for FANG’s 2026 earnings indicates 24.5% year-over-year growth. Valued at around $54.8 billion, FANG’s shares have soared 105.5% in a year.
2026-06-12 16:04 2mo ago
2026-04-29 06:30 4mo ago
Delek US Holdings Reports First Quarter 2026 Results
DK Delek US Energy
FMP Stock News
Original source text
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Delek US Holdings, Inc. (NYSE: DK) (“Delek US”, "Company") today announced financial results for its first quarter ended March 31, 2026.

“2026 is off to a strong start as we continue to build on the momentum established last year, further enhancing our cash flow profile through disciplined execution of our Enterprise Optimization Plan and advancing several other value creation initiatives,” said Avigal Soreq, President and Chief Executive Officer of Delek US. “A key highlight of the quarter was the successful completion of our Big Spring refinery turnaround, which was executed safely, on time, and on budget. With the full system now back online, we are well positioned to capture improved margins and meet demand during the upcoming driving season.”

“Delek Logistics Partners continues to demonstrate the strength and resilience of its integrated 3 stream service business model, supported by increasing third-party cash flows and optimization of its existing asset base. The steady ramp-up of our Delaware Basin Libby 2 Plant and our comprehensive sour gas capabilities reinforce DKL’s competitive position and support its attractive 2026 outlook. The economic separation between DK and DKL continues to increase, enhancing DKL’s financial flexibility and increasing valuation visibility at DK and DKL on a standalone basis.”

“Looking ahead, we are excited about the remainder of the year as we operate our full system and leverage our enhanced reliability to drive performance. We remain focused on safe and efficient operations, disciplined capital allocation, and adding incremental value creating initiatives to achieve our Sum of the Parts goals,” Soreq concluded.

Delek US Results

Three Months Ended March 31,

($ in millions, except per share data)

2026

2025

Net income (loss) attributable to Delek

$

(201.3

)

$

(172.7

)

Total diluted income (loss) per share

$

(3.34

)

$

(2.78

)

Adjusted net income (loss)

$

4.7

$

(144.4

)

Adjusted net income (loss) per share

$

0.08

$

(2.32

)

Adjusted EBITDA

$

211.7

$

33.6

Refining Segment

The refining segment Adjusted EBITDA was $155.3 million in the first quarter 2026 compared with $(27.0) million in the same quarter last year, which reflects an increase in refining margin driven by increased crack spreads. During the first quarter 2026, Delek US's benchmark crack spreads were up an average of 63.8% from prior-year levels. Adjusted EBITDA was also impacted by inventory adjustments of $(17.6) million and $26.2 million for first quarter 2026 and 2025, respectively.

Logistics Segment

The logistics segment Adjusted EBITDA in the first quarter 2026 was $132.4 million compared with $123.2 million in the prior-year quarter. The increase over last year's first quarter reflects higher margins in the wholesale business and increased interest income related to sales-type leases.

Shareholder Distributions

On April 20, 2026, the Board of Directors approved the regular quarterly dividend of $0.255 per share that will be paid on May 8, 2026 to shareholders of record on May 1, 2026.

Liquidity

As of March 31, 2026, Delek US had a cash balance of $624.1 million and total consolidated long-term debt of $3,183.1 million, resulting in net debt of $2,559.0 million. As of March 31, 2026, Delek Logistics Partners, LP (NYSE: DKL) ("Delek Logistics") had $9.9 million of cash and $2,294.6 million of total long-term debt, which are included in the consolidated amounts on Delek US' balance sheet. Excluding Delek Logistics, Delek US had $614.2 million in cash and $888.5 million of long-term debt, or a $274.3 million net debt position.

First Quarter 2026 Results | Conference Call Information

Delek US will hold a conference call to discuss its first quarter 2026 results on Wednesday, April 29, 2026 at 9:00 a.m. Central Time. Investors will have the opportunity to listen to the conference call live by going to www.DelekUS.com and clicking on the Investor Relations tab. Participants are encouraged to register at least 15 minutes early to download and install any necessary software. Presentation materials accompanying the call will be available on the investor relations tab of the Delek US website approximately ten minutes prior to the start of the call. For those who cannot listen to the live broadcast, the online replay will be available on the website for 90 days.

Investors may also wish to listen to Delek Logistics’ (NYSE: DKL) first quarter 2026 earnings conference call that will be held on Wednesday, April 29, 2026 at 11:30 a.m. Central Time and review Delek Logistics’ earnings press release. Market trends and information disclosed by Delek Logistics may be relevant to the logistics segment reported by Delek US. Both a replay of the conference call and press release for Delek Logistics will be available online at www.deleklogistics.com.

About Delek US Holdings, Inc.

Delek US Holdings, Inc. is a diversified downstream energy company with assets in petroleum refining, logistics, pipelines, and renewable fuels. The refining assets consist primarily of refineries operated in Tyler and Big Spring, Texas, El Dorado, Arkansas and Krotz Springs, Louisiana with a combined nameplate crude throughput capacity of 302,000 barrels per day.

The logistics operations include Delek Logistics Partners, LP (NYSE: DKL). Delek Logistics Partners, LP is a growth-oriented master limited partnership focused on owning and operating midstream energy infrastructure assets. Delek US Holdings, Inc. and its subsidiaries owned approximately 63.3% (including the general partner interest) of Delek Logistics Partners, LP at March 31, 2026.

Safe Harbor Provisions Regarding Forward-Looking Statements

This press release contains forward-looking statements that are based upon current expectations and involve a number of risks and uncertainties. Statements concerning current estimates, expectations and projections about future results, performance, prospects, opportunities, plans, actions and events and other statements, concerns, or matters that are not historical facts are “forward-looking statements,” as that term is defined under the federal securities laws. These statements contain words such as “possible,” “believe,” “should,” “could,” “would,” “predict,” “plan,” “estimate,” “intend,” “may,” “anticipate,” “will,” “if", “potential,” “expect” or similar expressions, as well as statements in the future tense. These forward-looking statements include, but are not limited to, statements regarding anticipated performance and financial position; cost reductions; throughput at the Company’s refineries; crude oil prices, discounts and quality and our ability to benefit therefrom; growth; scheduled turnaround activity; projected capital expenditures and investments into our business; liquidity and EBITDA impacts from strategic and intercompany transactions; the performance of our midstream growth initiatives, and the flexibility, benefits and expected returns therefrom; and projected benefits of Delek Logistics' acquisition of the Delaware Gathering, Permian Gathering, H2O Midstream and Gravity Water Midstream businesses.

Investors are cautioned that the following important factors, among others, may affect these forward-looking statements: political or regulatory developments, including tariffs, taxes and changes in governmental policies relating to crude oil, natural gas, refined products or renewables; uncertainty related to timing and amount of future share repurchases and dividend payments; risks and uncertainties with respect to the quantities and costs of crude oil we are able to obtain and the price of the refined petroleum products we ultimately sell, uncertainties regarding actions by OPEC and non-OPEC oil producing countries impacting crude oil production and pricing; risks and uncertainties related to the integration by Delek Logistics of the Delaware Gathering, Permian Gathering, H2O Midstream or Gravity businesses following their acquisition; Delek US' ability to realize cost reductions; risks related to exposure to Permian Basin crude oil, such as supply, pricing, gathering, production and transportation capacity; gains and losses from derivative instruments; risks associated with acquisitions and dispositions; risks and uncertainties with respect to the possible benefits of the H2O Midstream and Gravity transactions; acquired assets may suffer a diminishment in fair value as a result of which we may need to record a write-down or impairment in carrying value of the asset; the possibility of litigation challenging and/or legislation changing renewable fuel standard waivers; changes in the scope, costs, and/or timing of capital and maintenance projects; the ability to grow the Midland Gathering System; the ability of the Red River joint venture to complete the expansion project to increase the Red River pipeline capacity; operating hazards inherent in transporting, storing and processing crude oil and intermediate and finished petroleum products; our competitive position and the effects of competition; the projected growth of the industries in which we operate; general economic and business conditions affecting the geographic areas in which we operate; and other risks described in Delek US’ filings with the United States Securities and Exchange Commission (the “SEC”), including risks disclosed in our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other filings and reports with the SEC.

Forward-looking statements should not be read as a guarantee of future performance or results and will not be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking information is based on information available at the time and/or management's good faith belief with respect to future events, and is subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the statements. Delek US undertakes no obligation to update or revise any such forward-looking statements to reflect events or circumstances that occur, or which Delek US becomes aware of, after the date hereof, except as required by applicable law or regulation.

Non-GAAP Disclosures:

Our management uses certain “non-GAAP” operational measures to evaluate our operating segment performance and non-GAAP financial measures to evaluate past performance and prospects for the future to supplement our financial information presented in accordance with United States ("U.S.") Generally Accepted Accounting Principles ("GAAP"). These financial and operational non-GAAP measures are important factors in assessing our operating results and profitability and include:

Adjusting items - certain identified infrequently occurring items, non-cash items, and items that are not attributable to or indicative of our on-going operations or that may obscure our underlying results and trends; Adjusted net income (loss) - calculated as net income (loss) attributable to Delek US adjusted for relevant Adjusting items recorded during the period; Adjusted net income (loss) per share - calculated as Adjusted net income (loss) divided by weighted average shares outstanding, assuming dilution, as adjusted for any anti-dilutive instruments that may not be permitted for consideration in GAAP earnings per share calculations but that nonetheless favorably impact dilution; Earnings before interest, taxes, depreciation and amortization ("EBITDA") - calculated as net income (loss) attributable to Delek adjusted to add back interest expense, income tax expense, depreciation, amortization and proportional interest, taxes, depreciation and amortization of equity method investments; Adjusted EBITDA - calculated as EBITDA adjusted for the relevant identified Adjusting items in Adjusted net income (loss) that do not relate to interest expense, income tax expense, depreciation or amortization, and adjusted to include income (loss) attributable to non-controlling interests; Refining margin - calculated as gross margin (which we define as sales minus cost of sales) adjusted for operating expenses and depreciation and amortization included in cost of sales; Adjusted refining margin - calculated as refining margin adjusted for other inventory impacts, net inventory LCM valuation loss (benefit), unrealized hedging (gain) loss and intercompany lease impacts; Refining production margin - calculated based on the regional market sales price of refined products produced, less allocated transportation, Renewable Fuel Standard volume obligation and associated feedstock costs. This measure reflects the economics of each refinery exclusive of the financial impact of inventory price risk mitigation programs and marketing uplift strategies; Refining production margin per throughput barrel - calculated as refining production margin divided by our average refining throughput in barrels per day (excluding purchased barrels) multiplied by 1,000 and multiplied by the number of days in the period; and Net debt - calculated as long-term debt including both current and non-current portions (the most comparable GAAP measure) less cash and cash equivalents as of a specific balance sheet date. We believe these non-GAAP operational and financial measures are useful to investors, lenders, ratings agencies and analysts to assess our ongoing performance because, when reconciled to their most comparable GAAP financial measure, they provide improved relevant comparability between periods, to peers or to market metrics through the inclusion of retroactive regulatory or other adjustments as if they had occurred in the prior periods they relate to, or through the exclusion of certain items that we believe are not indicative of our core operating performance and that may obscure our underlying results and trends. “Net debt,” also a non-GAAP financial measure, is an important measure to monitor leverage and evaluate the balance sheet.

Non-GAAP measures have important limitations as analytical tools, because they exclude some, but not all, items that affect net earnings and operating income. These measures should not be considered substitutes for their most directly comparable U.S. GAAP financial measures. Additionally, because Adjusted net income or loss, Adjusted net income or loss per share, EBITDA and Adjusted EBITDA, Adjusted Refining Margin and Refining Production Margin or any of our other identified non-GAAP measures may be defined differently by other companies in its industry, Delek US' definition may not be comparable to similarly titled measures of other companies. See the accompanying tables in this earnings release for a reconciliation of these non-GAAP measures to the most directly comparable GAAP measures.

Delek US Holdings, Inc.

Condensed Consolidated Balance Sheets (Unaudited)

($ in millions, except share and per share data)

March 31, 2026

December 31, 2025

ASSETS

Current assets:

Cash and cash equivalents

$

624.1

$

625.8

Accounts receivable, net

942.7

648.7

Inventories, net of inventory valuation reserves

931.0

726.0

Other current assets

149.9

67.5

Total current assets

2,647.7

2,068.0

Property, plant and equipment:

Property, plant and equipment

5,811.3

5,586.9

Less: accumulated depreciation

(2,399.9

)

(2,314.4

)

Property, plant and equipment, net

3,411.4

3,272.5

Operating lease right-of-use assets

69.9

71.4

Goodwill

475.3

475.3

Other intangibles, net

404.2

405.7

Equity method investments

424.4

427.7

Other non-current assets

137.0

127.1

Total assets

$

7,569.9

$

6,847.7

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Accounts payable

$

2,309.7

$

1,633.8

Current portion of long-term debt

9.5

9.5

Current portion of operating lease liabilities

26.3

27.2

Accrued expenses and other current liabilities

1,149.1

858.9

Total current liabilities

3,494.6

2,529.4

Non-current liabilities:

Long-term debt, net of current portion

3,173.6

3,223.6

Obligation under Inventory Intermediation Agreement

230.5

119.5

Environmental liabilities, net of current portion

30.9

31.1

Asset retirement obligations

35.1

34.0

Deferred tax liabilities

159.5

217.9

Operating lease liabilities, net of current portion

42.9

46.1

Other non-current liabilities

100.8

98.8

Total non-current liabilities

3,773.3

3,771.0

Stockholders’ equity:

Preferred stock, $0.01 par value, 10,000,000 shares authorized, no shares issued and outstanding





Common stock, $0.01 par value, 110,000,000 shares authorized, 78,793,863 shares and 77,357,447 shares issued at March 31, 2026, and December 31, 2025, respectively

0.8

0.8

Additional paid-in capital

1,274.4

1,290.9

Accumulated other comprehensive loss





Treasury stock, 17,575,527 shares, at cost, at March 31, 2026, and December 31, 2025, respectively

(694.1

)

(694.1

)

Retained earnings (deficit)

(528.6

)

(311.1

)

Non-controlling interests in subsidiaries

249.5

260.8

Total stockholders’ equity

302.0

547.3

Total liabilities and stockholders’ equity

$

7,569.9

$

6,847.7

  Delek US Holdings, Inc.

Condensed Consolidated Statements of Income (Loss) (Unaudited)

($ in millions, except share and per share data)

Three Months Ended March 31,

2026

2025

Net revenues

$

2,653.1

$

2,641.9

Cost of sales:

Cost of materials and other

2,465.8

2,399.5

Operating expenses (excluding depreciation and amortization presented below)

219.9

211.1

Depreciation and amortization

97.6

95.0

Total cost of sales

2,783.3

2,705.6

Operating expenses related to wholesale business (excluding depreciation and amortization presented below)

1.6

1.3

General and administrative expenses

44.0

61.5

Depreciation and amortization

5.7

6.3

Asset impairment





Other operating expense (income), net

(2.2

)

(7.0

)

Total operating costs and expenses

2,832.4

2,767.7

Operating income (loss)

(179.3

)

(125.8

)

Interest expense, net

84.5

84.1

Income from equity method investments

(14.6

)

(13.3

)

Other expense (income), net

(0.3

)

(1.6

)

Total non-operating expense, net

69.6

69.2

Income (loss) from continuing operations before income tax expense (benefit)

(248.9

)

(195.0

)

Income tax expense (benefit)

(58.2

)

(36.8

)

Income (loss) from continuing operations, net of tax

(190.7

)

(158.2

)

Discontinued operations:

Income (loss) from discontinued operations

(0.3

)

(0.4

)

Income tax expense (benefit)

(0.1

)

(0.1

)

Income (loss) from discontinued operations, net of tax

(0.2

)

(0.3

)

Net income (loss)

(190.9

)

(158.5

)

Net income attributed to non-controlling interests

10.4

14.2

Net income (loss) attributable to Delek

$

(201.3

)

$

(172.7

)

Basic income (loss) per share:

Income (loss) from continuing operations

$

(3.34

)

$

(2.78

)

Income (loss) from discontinued operations

$



$



Total basic income (loss) per share

$

(3.34

)

$

(2.78

)

Diluted income (loss) per share:

Income (loss) from continuing operations

$

(3.34

)

$

(2.78

)

Income (loss) from discontinued operations

$



$



Total diluted income (loss) per share

$

(3.34

)

$

(2.78

)

Weighted average common shares outstanding:

Basic

60,255,377

62,115,776

Diluted

60,255,377

62,115,776

  Delek US Holdings, Inc.

Condensed Consolidated Cash Flow Data (Unaudited)

($ in millions)

Three Months Ended March 31,

2026

2025

Cash flows from operating activities:

Cash provided by (used in) operating activities - continuing operations

$

461.3

$

(62.1

)

Cash provided by (used in) operating activities - discontinued operations

(0.2

)

(0.3

)

Net cash provided by (used in) operating activities

461.1

(62.4

)

Cash flows from investing activities:

Net cash used in investing activities

(190.3

)

(314.6

)

Cash flows from financing activities:

Net cash provided by (used in) financing activities

(272.5

)

265.2

Net decrease in cash and cash equivalents

(1.7

)

(111.8

)

Cash and cash equivalents at the beginning of the period

625.8

735.6

Cash and cash equivalents at the end of the period

624.1

623.8

Working Capital Impacts Included in Cash Flows from Operating Activities from Continuing Operations

($ in millions)

Three Months Ended March 31,

2026

2025

Favorable (unfavorable) cash flow working capital changes (1)

$

600.9

$

25.6

(1) Includes obligations under the inventory intermediation agreement.

Significant Transactions During the Quarter Impacting Results:

Restructuring Costs

In 2022, we announced that we are progressing a business transformation focused on enterprise-wide opportunities to improve the efficiency of our cost structure. For the first quarter 2026, we recorded restructuring costs totaling $2.7 million ($2.1 million after-tax) associated with our business transformation. Restructuring costs of $1.7 million are recorded in general and administrative expenses and $1.0 million are included in operating expenses in our condensed consolidated statements of income.

General and Administrative Expenses

Excluding transaction costs and restructuring costs, general and administrative expenses were $40.2 million for the three months ended March 31, 2026.

Transactions with Delek Logistics

In January 2026, we entered into asset purchase agreements with Delek Logistics, pursuant to which we agreed to acquire a Tyler refinery tank for total consideration of $19.0 million and El Dorado tank and terminal assets for total consideration of $66.0 million. The Tyler Tank Purchase closed on April 1, 2026 with consideration paid through transfer of Delek Logistics common units, based on a 30-day volume weighted average unit price. The El Dorado Terminal Purchase is expected to close on October 1, 2027, subject to the satisfaction of customary closing conditions.

Other Inventory Impact

"Other inventory impact" is primarily calculated by multiplying the number of barrels sold during the period by the difference between current period weighted average purchase cost per barrel directly related to our refineries and per barrel cost of materials and other for the period recognized on a first-in, first-out basis directly related to our refineries. It assumes no beginning or ending inventory, so that the current period average purchase cost per barrel is a reasonable estimate of our market purchase cost for the current period, without giving effect to any build or draw on beginning inventory. These amounts are based on management estimates using a methodology including these assumptions. However, this analysis provides management with a means to compare hypothetical refining margins to current period average crack spreads, as well as provides a means to better compare our results to peers.

Intercompany Leases

As a result of amendments to intercompany lease agreements in August 2024, we had to reassess lease classification for the agreements that contain leases under Accounting Standards Codification 842. As a result of these lease assessments, certain of these agreements met the criteria to be accounted for as sales-type leases for Delek Logistics and finance leases for the Refining segment. Therefore, portions of the minimum volume commitments under these agreements subject to sales-type lease accounting are recorded as interest income with the remaining amounts recorded as a reduction in net investment in leases. Prior to the amendments, these agreements were accounted for as operating leases and these minimum volume commitments were recorded as revenues in the Logistics segment. Similarly, these minimum volume commitments were previously recorded as costs of sales for the Refining segment, as the underlying lease was reclassified from an operating lease to a finance lease, and these payments are now recorded as interest expense and reductions in the lease liability. These accounting changes have no impact to the Delek US consolidated results as these amounts eliminate in consolidation.

Revolving Credit Facilities

On March 26, 2026, Delek Logistics Partners, LP entered into a new credit agreement that provides for revolving commitments up to $1,300.0 million in the aggregate with a sublimit up to $150.0 million for letters of credit and up to $50.0 million for swing line loans.

On April 9, 2026, the Company entered into Amendment No. 4 to Third Amended and Restated Credit Agreement. Amendment No. 4, among other modifications, (i) increases the revolving loan commitments from $1,100.0 million to $1,250.0 million, (ii) extends the maturity date of the Delek Revolving Credit Facility from October 26, 2027 to April 9, 2031, (iii) reduces the interest rate margins applicable to the Delek Revolving Credit Facility by 0.25% and (iv) amends certain thresholds for obligations under the Existing ABL Credit Agreement.

Reconciliation of Net Income (Loss) Attributable to Delek US to Adjusted Net Income (Loss)

Three Months Ended March 31,

$ in millions (unaudited)

2026

2025

Reported net income (loss) attributable to Delek US

$

(201.3

)

$

(172.7

)

Adjusting items (1)

Inventory and other LCM valuation (benefit) loss

(8.7

)

0.2

Tax effect

2.0



Inventory and other LCM valuation (benefit) loss, net

(6.7

)

0.2

Other inventory impact

(17.6

)

26.2

Tax effect

4.0

(5.9

)

Other inventory impact, net (2)

(13.6

)

20.3

Unrealized inventory/commodity hedging (gain) loss where the hedged item is not yet recognized in the financial statements

23.9

(1.6

)

Tax effect

(5.4

)

0.4

Unrealized inventory/commodity hedging (gain) loss where the hedged item is not yet recognized in the financial statements, net

18.5

(1.2

)

Transaction related expenses

2.1

3.5

Tax effect

(0.5

)

(0.8

)

Transaction related expenses, net

1.6

2.7

Unrealized changes in fair value of the net RINs obligation due to price of underlying RINs and related hedging on forward RIN contracts

180.8

(0.2

)

Tax effect

(40.7

)



Unrealized changes in fair value of the net RINs obligation due to price of underlying RINs and related hedging on forward RIN contracts, net

140.1

(0.2

)

Restructuring costs

2.7

8.4

Tax effect

(0.6

)

(1.9

)

Restructuring costs, net (2)

2.1

6.5

Renewable volume obligation short related to small refinery exemptions(4)

82.3



Tax effect

(18.5

)



Renewable volume obligation short related to small refinery exemptions, net

63.8



DPG inventory adjustment

0.3



Tax effect

(0.1

)



DPG inventory adjustment, net (3)

0.2



Total Adjusting items (1)

206.0

28.3

Adjusted net income (loss)

$

4.7

$

(144.4

)

Reconciliation of U.S. GAAP Income (Loss) per share to Adjusted Net Income (Loss) per share

Three Months Ended March 31,

$ per share (unaudited)

2026

2025

Reported diluted net income (loss) per share

$

(3.34

)

$

(2.78

)

Adjusting items, after tax (per share) (1) (2)

Net inventory and other LCM valuation (benefit) loss

(0.11

)



Other inventory impact (3)

(0.23

)

0.33

Unrealized inventory/commodity hedging (gain) loss where the hedged item is not yet recognized in the financial statements

0.31

(0.02

)

Unrealized changes in fair value of the net RINs obligation due to price of underlying RINs and related hedging on forward RIN contracts

2.33



Transaction related expenses

0.03

0.04

Restructuring costs (3)

0.03

0.11

Renewable volume obligation short related to small refinery exemptions (5)

1.06



DPG inventory adjustment, net (4)





Total Adjusting items (1)

3.42

0.46

Adjusted net income (loss) per share

$

0.08

$

(2.32

)

(1)

The adjustments have been tax effected using the estimated marginal tax rate, as applicable.

(2) For periods of Adjusted net loss, Adjustments (Adjusting items) and Adjusted net loss per share are presented using basic weighted average shares outstanding.

(3) See further discussion in the "Significant Transactions During the Quarter Impacting Results" section.

(4) Starting with the quarter ended June 30, 2025, we updated our non-GAAP financial measures to include the impact of the DPG inventory for price and volume inventory impacts. The impact to historical non-GAAP financial measures is immaterial.

(5) Starting with the quarter ended September 30, 2025, we have updated our non-GAAP financial measures to include the benefit related to small refinery exemptions expected to be received specific to the current year obligation based on current laws and regulations. Consistent with our historical accounting practice, we have recorded the full amount of our Consolidated Net RINs Obligation assuming no future exemptions are granted. However, based on our history of being granted the exemptions and expected future activity, we have adjusted the non-GAAP measure to include the benefit of receiving exemptions equal to approximately 50% of our recorded current-period obligation.

Reconciliation of Net Income (Loss) attributable to Delek US to Adjusted EBITDA

Three Months Ended March 31,

$ in millions (unaudited)

2026

2025

Reported net income (loss) attributable to Delek US

$

(201.3

)

$

(172.7

)

Add:

Interest expense, net

84.5

84.1

Income tax expense (benefit)

(58.3

)

(36.9

)

Depreciation and amortization

103.3

101.3

Proportional interest, taxes, depreciation and amortization from equity-method investments

7.3

7.1

EBITDA attributable to Delek US

(64.5

)

(17.1

)

Adjusting items

Net inventory and other LCM valuation (benefit) loss

(8.7

)

0.2

Other inventory impact (1)

(17.6

)

26.2

Unrealized inventory/commodity hedging (gain) loss where the hedged item is not yet recognized in the financial statements

23.9

(1.6

)

Unrealized changes in fair value of the net RINs obligation due to price of underlying RINs and related hedging on forward RIN contracts

180.8

(0.2

)

Transaction related expenses

2.1

3.5

Restructuring costs (1)

2.7

8.4

Renewable volume obligation short related to small refinery exemptions(3)

82.3



DPG inventory adjustment (2)

0.3



Net income attributable to non-controlling interest

10.4

14.2

Total Adjusting items

276.2

50.7

Adjusted EBITDA

$

211.7

$

33.6

Reconciliation of Segment EBITDA Attributable to Delek US to Adjusted Segment EBITDA

Three Months Ended March 31, 2026

$ in millions (unaudited)

Refining

Logistics

Segment Total

Corporate, Other and Eliminations

Consolidated

Segment EBITDA Attributable to Delek US

$

79.2

$

94.9

$

174.1

$

(238.6

)

$

(64.5

)

Adjusting items

Net inventory and other LCM valuation (benefit) loss

(8.7

)



(8.7

)



(8.7

)

Other inventory impact (1)

(17.6

)



(17.6

)



(17.6

)

Unrealized inventory/commodity hedging (gain) loss where the hedged item is not yet recognized in the financial statements

23.3

0.6

23.9



23.9

Unrealized changes in fair value of the net RINs obligation due to price of underlying RINs and related hedging on forward RIN contracts

22.3



22.3

158.5

180.8

Restructuring costs (1)







2.7

2.7

Transaction related expenses



1.2

1.2

0.9

2.1

Renewable volume obligation short related to small refinery exemptions (3)

82.3



82.3



82.3

DPG inventory adjustment (2)



0.3

0.3



0.3

Intercompany lease impacts (1)

(25.5

)

35.4

9.9

(9.9

)



Net income attributable to non-controlling interest







10.4

10.4

Total Adjusting items

76.1

37.5

113.6

162.6

276.2

Adjusted Segment EBITDA

$

155.3

$

132.4

$

287.7

$

(76.0

)

$

211.7

Three Months Ended March 31, 2025

$ in millions (unaudited)

Refining

Logistics

Segment Total

Corporate, Other and Eliminations

Consolidated

Segment EBITDA Attributable to Delek US

$

(15.8

)

$

92.2

$

76.4

$

(93.5

)

$

(17.1

)

Adjusting items

Net inventory and other LCM valuation (benefit) loss

0.2



0.2



0.2

Other inventory impact (1)

26.2



26.2



26.2

Unrealized inventory/commodity hedging (gain) loss where the hedged item is not yet recognized in the financial statements

(1.6

)



(1.6

)



(1.6

)

Unrealized changes in fair value of the net RINs obligation due to price of underlying RINs and related hedging on forward RIN contracts

(5.5

)



(5.5

)

5.3

(0.2

)

Restructuring costs

0.3



0.3

8.1

8.4

Transaction related expenses



3.3

3.3

0.2

3.5

Intercompany lease impacts (1)

(30.8

)

27.7

(3.1

)

3.1



Net income attributable to non-controlling interest







14.2

14.2

Total Adjusting items

(11.2

)

31.0

19.8

30.9

50.7

Adjusted Segment EBITDA

$

(27.0

)

$

123.2

$

96.2

$

(62.6

)

$

33.6

Refining Segment Selected Financial Information

Three Months Ended March 31,

2026

2025

Total Refining Segment

(Unaudited)

Days in period

90

90

Total sales volume - refined product (average barrels per day ("bpd")) (1)

274,376

294,892

Total production (average bpd)

257,659

285,570

Crude oil

238,338

272,183

Other feedstocks

21,692

17,020

Total throughput (average bpd)

260,030

289,203

Total refining production margin per bbl total throughput

$

12.13

$

5.75

Total refining operating expenses per bbl total throughput

$

6.16

$

6.00

Total refining production margin ($ in millions)

$

283.8

$

149.6

Supply, marketing and other ($ millions) (2)

(61.3

)

(23.7

)

Total adjusted refining margin ($ in millions)

$

222.5

$

125.9

Total crude slate details

Total crude slate: (% based on amount received in period)

WTI crude oil

80.4

%

66.2

%

Gulf Coast Sweet crude

4.6

%

8.7

%

Local Arkansas crude oil

3.7

%

3.8

%

Other

11.3

%

21.3

%

Crude utilization (% based on nameplate capacity) (4)

78.9

%

90.1

%

Tyler, TX Refinery

Days in period

90

90

Products manufactured (average bpd):

Gasoline

37,956

34,214

Diesel/Jet

30,236

30,415

Petrochemicals, LPG, NGLs

1,816

1,861

Other

22

1,405

Total production

70,030

67,895

Throughput (average bpd):

Crude oil

68,035

68,460

Other feedstocks

3,616

770

Total throughput

71,651

69,230

Tyler refining production margin ($ in millions)

$

104.9

$

48.7

Per barrel of throughput:

Tyler refining production margin

$

16.27

$

7.82

Operating expenses

$

5.64

$

5.69

Crude Slate: (% based on amount received in period)

WTI crude oil

79.5

%

73.7

%

East Texas crude oil

18.8

%

25.2

%

Other

1.7

%

1.1

%

Capture rate (3)

60.9

%

46.1

%

El Dorado, AR Refinery

Days in period

90

90

Products manufactured (average bpd):

Gasoline

37,534

37,350

Diesel/Jet

26,054

27,941

Petrochemicals, LPG, NGLs

1,304

941

Asphalt

5,362

6,843

Other

1,521

1,569

Total production

71,775

74,644

Throughput (average bpd):

Crude oil

69,909

71,921

Other feedstocks

2,933

3,840

Total throughput

72,842

75,761

Refining Segment Selected Financial Information (continued)

Three Months Ended March 31,

2026

2025

El Dorado refining production margin ($ in millions)

$

61.9

$

26.1

Per barrel of throughput:

El Dorado refining production margin

$

9.44

$

3.83

Operating expenses

$

5.68

$

5.16

Crude Slate: (% based on amount received in period)

WTI crude oil

85.5

%

68.5

%

Local Arkansas crude oil

12.9

%

14.4

%

Other

1.6

%

17.1

%

Capture rate (3)

35.3

%

22.6

%

Big Spring, TX Refinery

Days in period

90

90

Products manufactured (average bpd):

Gasoline

15,714

29,399

Diesel/Jet

10,463

19,023

Petrochemicals, LPG, NGLs

1,150

3,142

Asphalt

1,224

2,543

Other

1,802

3,878

Total production

30,353

57,985

Throughput (average bpd):

Crude oil

28,718

53,321

Other feedstocks

1,816

6,094

Total throughput

30,534

59,415

Big Spring refining production margin ($ in millions)

$

21.6

$

26.0

Per barrel of throughput:

Big Spring refining production margin

$

7.85

$

4.86

Operating expenses

$

10.21

$

8.36

Crude Slate: (% based on amount received in period)

WTI crude oil

72.3

%

62.7

%

WTS crude oil

27.7

%

37.3

%

Capture rate (3)

31.5

%

30.2

%

Krotz Springs, LA Refinery

Days in period

90

90

Products manufactured (average bpd):

Gasoline

46,713

43,163

Diesel/Jet

30,954

32,321

Heavy oils

1,567

3,231

Petrochemicals, LPG, NGLs

6,267

6,331

Other





Total production

85,501

85,046

Throughput (average bpd):

Crude oil

71,676

78,481

Other feedstocks

13,327

6,316

Total throughput

85,003

84,797

Krotz Springs refining production margin ($ in millions)

$

95.4

$

48.8

Per barrel of throughput:

Krotz Springs refining production margin

$

12.48

$

6.40

Operating expenses

$

5.57

$

5.36

Crude Slate: (% based on amount received in period)

WTI Crude

79.4

%

59.9

%

Gulf Coast Sweet Crude

16.0

%

30.3

%

Other

4.6

%

9.8

%

Capture rate (3)

55.3

%

52.5

%

Logistics Segment Selected Information

Three Months Ended March 31,

2026

2025

(Unaudited)

Gathering & Processing: (average bpd)

Lion Pipeline System:

Crude pipelines (non-gathered)

62,758

61,888

Refined products pipelines

44,658

56,010

SALA Gathering System

9,220

10,321

East Texas Crude Logistics System

27,284

26,918

Midland Gathering Assets

218,203

246,090

Plains Connection System

212,359

179,240

Delaware Gathering Assets:

Natural gas gathering and processing (Mcfd) (1)

63,903

59,809

Crude oil gathering (average bpd)

129,451

122,226

Water disposal and recycling (average bpd)

111,173

128,499

Midland Water Gathering System: (2)

Water disposal and recycling (average bpd) (2)(3)

565,411

632,972

Wholesale Marketing & Terminalling:

East Texas - Tyler Refinery sales volumes (average bpd) (4)



67,876

West Texas wholesale marketing throughputs (average bpd)

11,771

10,826

West Texas wholesale marketing margin per barrel

$

4.42

$

1.64

Terminalling throughputs (average bpd) (5)

135,744

135,404

(1)

Mcfd - average thousand cubic feet per day.

(2) Consists of volumes of H2O Midstream and Gravity.

(3) Gravity volumes in 2025 are from January 2, 2025 through March 31, 2025.

(4) Excludes jet fuel and petroleum coke.

(5) Consists of terminalling throughputs at our Tyler, Big Spring, Big Sandy and Mount Pleasant, Texas terminals, El Dorado and North Little Rock, Arkansas terminals and Memphis and Nashville, Tennessee terminals.

Supplemental Information

Schedule of Selected Segment Financial Data, Pricing Statistics Impacting our Refining Segment, and Other Reconciliations of Amounts Reported Under U.S. GAAP

Three Months Ended March 31, 2026

$ in millions (unaudited)

Refining

Logistics

Segment
Total

Corporate,

Other and Eliminations

Consolidated

Net revenues (excluding intercompany fees and revenues)

$

2,522.3

$

130.8

$

2,653.1

$



$

2,653.1

Inter-segment fees and revenues

108.2

166.7

274.9

(274.9

)



Total revenues

$

2,630.5

$

297.5

$

2,928.0

$

(274.9

)

$

2,653.1

Cost of sales

2,617.3

253.6

2,870.9

(87.6

)

2,783.3

Gross margin

$

13.2

$

43.9

$

57.1

$

(187.3

)

$

(130.2

)

Three Months Ended March 31, 2025

$ in millions (unaudited)

Refining

Logistics

Segment
Total

Corporate,

Other and Eliminations

Consolidated

Net revenues (excluding intercompany fees and revenues)

$

2,518.3

$

123.6

$

2,641.9

$



$

2,641.9

Inter-segment fees and revenues

90.0

126.3

216.3

(216.3

)



Total revenues

$

2,608.3

$

249.9

$

2,858.2

$

(216.3

)

$

2,641.9

Cost of sales

2,700.9

199.3

2,900.2

(194.6

)

2,705.6

Gross margin

$

(92.6

)

$

50.6

$

(42.0

)

$

(21.7

)

$

(63.7

)

Pricing Statistics

Three Months Ended March 31,

(average for the period presented)

2026

2025

WTI — Cushing crude oil (per barrel)

$

72.67

$

71.47

WTI — Midland crude oil (per barrel)

$

72.57

$

72.52

WTS — Midland crude oil (per barrel)

$

69.91

$

71.95

LLS (per barrel)

$

73.68

$

74.35

Brent (per barrel)

$

77.90

$

74.98

U.S. Gulf Coast 5-3-2 crack spread (per barrel) (1)

$

26.71

$

16.97

U.S. Gulf Coast 3-2-1 crack spread (per barrel) (1)

$

24.90

$

16.11

U.S. Gulf Coast 2-1-1 crack spread (per barrel) (1)

$

22.56

$

12.20

U.S. Gulf Coast Unleaded Gasoline (per gallon)

$

2.09

$

1.98

Gulf Coast Ultra-low sulfur diesel (per gallon)

$

2.74

$

2.29

U.S. Gulf Coast high sulfur diesel (per gallon)

$

2.49

$

2.12

Natural gas (per MMBTU)

$

3.48

$

3.87

Other Reconciliations of Amounts Reported Under U.S. GAAP

$ in millions (unaudited)

Three Months Ended March 31,

Reconciliation of gross margin to Refining margin to Adjusted refining margin

2026

2025

Gross margin

$

13.2

$

(92.6

)

Add back (items included in cost of sales):

Operating expenses (excluding depreciation and amortization)

150.2

158.1

Depreciation and amortization

65.3

71.9

Refining margin

$

228.7

$

137.4

Adjusting items

Net inventory and other LCM valuation loss (benefit)

(8.7

)

0.2

Other inventory impact (1)

(17.6

)

26.2

Unrealized inventory/commodity hedging (gain) loss where the hedged item is not yet recognized in the financial statements

23.3

(1.6

)

Unrealized RINs hedging (gain) loss where the hedged item is not yet recognized in the financial statements

22.3

(5.5

)

Intercompany lease impacts (1)

(25.5

)

(30.8

)

Total Adjusting items

(6.2

)

(11.5

)

Adjusted refining margin

$

222.5

$

125.9

(1) See further discussion in the "Significant Transactions During the Quarter Impacting Results" section.

Calculation of Net Debt

March 31, 2026

December 31, 2025

Long-term debt - current portion

$

9.5

$

9.5

Long-term debt - non-current portion

3,173.6

3,223.6

Total long-term debt

3,183.1

3,233.1

Less: Cash and cash equivalents

624.1

625.8

Net debt - consolidated

2,559.0

2,607.3

Less: DKL net debt

2,284.7

2,333.5

Net debt, excluding DKL

$

274.3

$

273.8

More News From Delek US Holdings, Inc.
2026-06-12 16:03 2mo ago
2026-04-29 13:12 4mo ago
Delek US Holdings, Inc. (DK) Q1 2026 Earnings Call Transcript
DK Delek US Energy
FMP Stock News
Original source text
Delek US Holdings, Inc. (DK) Q1 2026 Earnings Call Transcript
2026-06-12 16:03 2mo ago
2026-04-29 14:31 4mo ago
Why Delek Holdings Rallied Big Today
DK Delek US Energy
FMP Stock News
Original source text
Shares of Delek U.S. Holdings (DK +2.00%) rallied 15.1% on Wednesday as of 1:14 p.m. EDT.

The small refinery and oil and gas logistics company rallied on the back of better-than-expected earnings today, along with a relatively strong day for oil and gas names amid higher oil prices.

Delek is benefiting from very jet fuel high refining margins amid the current macroeconomic environment. Moreover, the company is also undergoing some "self-help" with a large cost-cutting program, as well as the ongoing separation of its refining and logistics segments.

Today's Change

(

2.00

%) $

0.94

Current Price

$

48.01

Delek delivers fuel for profits In the first quarter, Delek grew revenue by 0.4% to $2.65 billion, with an adjusted (non-GAAP) loss per share of ($0.98).

While those numbers don't seem especially good, they were ahead of expectations. Notably, Delek's Big Spring refinery was down for maintenance in the quarter, which affected revenue and earnings in the short-term but positions the company for higher efficiency and margins going forward.

Not only is the Big Spring turnaround maintenance now complete, but Delek is also underway with a significant cost-cutting program. On the release, management announced it had increased its annualized cash flow savings from the program from $200 million to $220 million.

Delek also has a particularly advantageous position, with a higher proportion of its refining capacity dedicated to jet fuel yield than other refiners. Those margins are particularly high right now. The refining segment's adjusted EBITDA increased to $155.3 million, up massively from a $27 million loss in the year-ago quarter.

Image source: Getty Images.

Delek's management believes in more upside In a slide on the presentation, Delek believes its "mid-cycle" adjusted EBITDA is around $545 million. Attributing a 4.5 times multiple to its refining operations, Delek believes its enterprise value should be about $2.45 billion -- a little below where it is now.

However, Delek also has other assets. Notably, Delek owns a 63% stake in Delek Logistics Partners (DKL 4.01%), which is worth another $1.71 billion at the current valuation.

Finally, Delek qualifies for small-refinery exemption payments (SREs) from the government, which help small refiners cover their high compliance costs. Those could increase adjusted EBITDA by $375 million to $750 million, depending on the number of SREs granted.

All in all, Delek's management believes the sum of these parts adds up to a stock price that's roughly double where Delek trades today, even after today's surge.
2026-06-12 16:03 2mo ago
2026-04-29 18:27 4mo ago
Delek US Holdings Inc (DK) Stock Up 13.7% but GF Value Says Overvalued -- GF Score: 56/100
DK Delek US Energy
FMP Stock News
Original source text
On April 29, 2026, Delek US Holdings Inc (DK) shares rose 13.7% to a current price of $46.67. The stock has shown remarkable volatility, with a 52-week range be
2026-06-12 16:03 2mo ago
2026-05-01 10:11 4mo ago
Why Delek U.S. Holdings Is Rising This Week
DK Delek US Energy
FMP Stock News
Original source text
Powering past the 1.4% rise that the S&P 500 has logged from the end of trading last Friday through yesterday's market close, shares of downstream energy specialist Delek U.S. Holdings (DK +2.00%) are ripping higher thanks to the company's recent reporting of strong first-quarter 2026 financial results.

According to data provided by S&P Global Market Intelligence, Delek U.S. Holdings is up 17.5% from the close of last Friday's trading session through the end of yesterdays' trading.

Image source: Getty Images.

The company's optimization plan continues to produce results Beating analysts' expectations that it would report revenue of $2.42 billion, Delek U.S. Holdings reported Q1 2026 sales of $2.65 billion on Wednesday. The bottom of the income statement also surprised investors as the company reported adjusted earnings per share of negative $0.98 -- a narrower loss than the negative $1.62 that analysts had anticipated.

Today's Change

(

2.00

%) $

0.94

Current Price

$

48.01

Management largely credited the strong financial results to the success of the company's Enterprise Optimization Plan (EOP), which, among other things, has helped the company achieve higher distillate and jet fuel yields. It's not merely the recent quarter that has illustrated the success of the EOP. Management announced -- for the sixth time -- higher expectations for how the EOP will improve cash flow, projecting an annual run rate improvement of $220 million.

This refining specialist's stock still has room to run While Delek U.S. Holdings' stock has raced higher this week, investors shouldn't expect a pullback anytime soon. If the EOP continues to deliver benefits and the company's financials keep improving, investors will likely keep bidding the energy stock higher.

Scott Levine has no position in any of the stocks mentioned. The Motley Fool recommends Delek Us. The Motley Fool has a disclosure policy.
2026-06-12 16:03 2mo ago
2026-05-04 11:10 4mo ago
Delek US Q1 Earnings & Revenues Beat Estimates, Adjusted EBITDA Up Y/Y
DK Delek US Energy
FMP Stock News
Original source text
Key Takeaways DK reported Q1 adjusted EPS of 8 cents, beating the loss estimate and improving from the prior-year loss.DK saw EBITDA jump 530% to $211.7M, driven by stronger crack spreads and SRE benefits.DK refining profit surged on higher margins, while logistics EBITDA rose on improved wholesale margins. Delek US Holdings, Inc. (DK - Free Report) reported first-quarter 2026 adjusted earnings of 8 cents per share, in contrast to the Zacks Consensus Estimate of a loss of $1.56. The bottom line also improved 103.4% from the year-ago adjusted loss of $2.32, supported by stronger year-over-year performance across both segments.

Net revenues increased 0.4% year over year to $2.7 billion. The top line also beat the Zacks Consensus Estimate by 27.5%. This was due to better-than-expected performance from the refining segment, which exceeded our consensus mark by $93 million.

The integrated downstream energy company reported adjusted EBITDA of $211.7 million, up 530.1% from $33.6 million a year earlier, aided by stronger crack spreads and the quarter’s impact from small refinery exemptions (“SRE”).

On April 20, 2026, DK’s board of directors approved the regular quarterly dividend of 25.5 cents per share. The dividend will be paid on May 8, 2026, to its shareholders of record as of May 1.

DK’s Segmental PerformancesRefining: The refining segment reported an adjusted EBITDA profit of $155.3 million, a notable increase from the adjusted EBITDA loss of $27 million recorded in the prior-year quarter. However, the reported figure missed our estimate of $185.5 million.

The strong year-over-year profit growth was mainly fueled by higher refining margins, supported by an expansion in crack spreads. Delek US’ benchmark crack spreads rose an average of 63.8% year over year during the first quarter of 2026.

Logistics: This unit represents Delek US’ majority interest in Delek Logistics Partners (DKL - Free Report) , a publicly traded master limited partnership that owns, operates, develops and acquires pipelines and other midstream assets.

In the first quarter, the segment registered an adjusted EBITDA of $132.4 million compared with $123.2 million in the year-ago quarter. The year-over-year growth was driven by improved margins in the wholesale segment, along with higher interest income from sales-type leases. However, the figure missed our estimate of $141.2 million.

DK’s FinancialsTotal operating costs and expenses increased 2.3% year over year to $2.8 billion. Moreover, the figure was higher than our estimate of $2 billion. Operating expenses (excluding depreciation and amortization) were $219.9 million compared with $211.1 million a year ago, while general and administrative expenses declined to $44 million from $61.5 million. Delek US spent $209 million on capital programs in the same time frame.

As of March 31, 2026, the company had cash and cash equivalents worth $624.1 million and long-term debt of $3.2 billion, with a debt-to-total capital of about 91.3%.

Cash provided by operating activities was $461.1 million in the quarter, versus cash used in operating activities of $62.4 million a year ago. The company reported $600.9 million of favorable working-capital changes within operating cash flow for the period.

DK’s Q2 and 2026 GuidanceFor the second quarter of 2026, DK expects throughput of 72,000-77,000 bpd at Tyler, 78,000-83,000 bpd at El Dorado, 65,000-70,000 bpd at Big Spring and 78,000-83,000 bpd at Krotz Springs. The company’s implied system throughput target is 293,000-313,000 bpd and the Crude throughput target is 283,000-303,000 bpd.

On the cost side, DK expects operating expenses of $215-$225 million, general and administrative expenses of $47-$52 million, depreciation and amortization of $105-$115 million and net interest expense of $80-$90 million for the second quarter.

For 2026, management continues to emphasize free cash flow improvement initiatives and midstream strength. The company raised its Enterprise Optimization Plan target for a sixth consecutive time to at least $220 million on an annual run-rate basis, with most of the improvement expected to come from margin enhancement across refining, logistics and wholesale operations. DK currently sports a Zacks Rank #1 (Strong Buy), while DKL has a Zacks Rank #5 (Strong Sell).

You can see the complete list of today’s Zacks #1 Rank stocks here.

Important Earnings at a GlanceWhile we have discussed DK’s first-quarter results in detail, let us take a look at three other key reports in this space.

Halliburton Company (HAL - Free Report) , a Houston, TX-based oil and gas equipment and services provider, posted first-quarter 2026 adjusted net income per share of 55 cents, beating the Zacks Consensus Estimate of 49 cents. The outperformance primarily reflects successful cost reduction initiatives. However, the bottom line fell from the year-ago adjusted profit of 60 cents.

Halliburton reported first-quarter capital expenditure of $192 million. As of March 31, 2026, this Houston, TX-based oil and gas equipment and services company had approximately $2 billion in cash/cash equivalents and $7.1 billion in long-term debt, representing a debt-to-capitalization ratio of 39.6.

Kinder Morgan Inc. (KMI - Free Report) , a Houston, TX-based oil and gas storage and transportation company,posted first-quarter 2026 adjusted earnings per share of 48 cents, which beat the Zacks Consensus Estimate of 38 cents. The bottom line increased year over year from 34 cents. The strong quarterly results can be primarily attributed to contributions from the Natural Gas Pipelines business segment.

As of March 31, 2026, KMI reported $72 million in cash and cash equivalents. At the quarter's end, its long-term debt amounted to $29.72 billion. KMI’s project backlog was reported at $10.1 billion by the end of the first quarter. The midstream energy major added that natural gas projects comprise approximately 92% of its project backlog, with nearly 60% dedicated to supporting local distribution companies and power generation.
2026-06-12 16:03 2mo ago
2026-05-11 17:06 4mo ago
Delek's Chairman of the Board Sold 34,000 Shares for $1.6 Million After Q1 Earnings
DK Delek US Energy
FMP Stock News
Original source text
Uzi Yemin, Director of Delek US Holdings, Inc. (DK +2.00%), reported an open-market sale of 34,026 shares for a total of ~$1.61 million on May 4, 2026, according to an SEC Form 4 filing.

Transaction summaryMetricValueShares sold (indirect)34,026Transaction value$1.6 millionPost-transaction shares (direct)210,281Post-transaction shares (indirect)447,795Post-transaction value (direct ownership)$10.1 millionTransaction value based on SEC Form 4 reported price ($47.29); post-transaction value based on May 4, 2026, market close ($48.04).

Key questionsWhat is the proportional impact of this sale on Yemin's overall and indirect holdings?
The transaction left Yemin with 447,795 shares held indirectly and 210,281 shares held directly.How was the transaction executed in terms of ownership structure?
All 34,026 shares disposed were held through By Yemin Investments, LP, with no direct shares sold or transferred in this event.Does the trade size reflect a change in selling behavior or capacity?
While the absolute trade size is lower than several prior sales, this is explained by a diminished share base, as Yemin's recent transactions have reduced available inventory.How does the sale align with broader company and market context?
Delek U.S. Holdings, Inc. shares had appreciated 248.4% over the trailing year as of May 4, 2026, providing a favorable environment for scheduled liquidity events under pre-arranged 10b5-1 plans.Company overviewMetricValueRevenue (TTM)$10.73 billionNet income (TTM)($48.5 million)Dividend yield2.22%1-year price change248.4%* 1-year price change calculated using May 4, 2026, as the reference date.

Company snapshotProduces and markets refined petroleum products including gasoline, diesel, aviation fuel, asphalt, and operates convenience retail stores and biodiesel facilities.Operates an integrated downstream energy model with revenue generated from refining, logistics (transportation and storage), and retail fuel sales.Serves oil companies, independent refiners and marketers, distributors, utility and transportation companies, the U.S. government, and independent retail fuel operators.Delek US Holdings, Inc. is a diversified downstream energy company with significant operations in refining, logistics, and retail. The company leverages its network of refineries, pipelines, and convenience stores to deliver a broad range of petroleum-based products across the southern United States.

Its integrated business model enables Delek to capture value at multiple stages of the supply chain, supporting resilience in a cyclical industry and providing flexibility to serve a wide range of wholesale and retail customers.

Today's Change

(

2.00

%) $

0.94

Current Price

$

48.01

What this transaction means for investorsYemin’s $1.6 million share sale involved indirect ownership via By Yemin Investments and was pursuant to a 10b5-1 plan, which is a written contract that allows corporate insiders to buy or sell company stock at predetermined times or amounts, providing a defense against allegations of insider trading. That said, with the stock up nearly 250% over the last year, the move certainly came at a lucrative time for Yemin, who serves as chairman of Delek’s board of directors.

On April 29, the company released its results for the first quarter of 2026, and the stock rose substantially following the report. Delek reported a net loss of $201.3 million or $3.34 per share, adjusted net income of $4.7 million or $0.08 per share, and adjusted EBITDA of $211.7 million, beating analyst estimates.

The company’s “Enterprise Optimization Plan (EOP)” appears to be working, as the company increased its annual run rate cash flow to $220 million from $200 million. The diversified downstream energy company also announced a quarterly dividend of $0.255 per share, which may appeal to income investors.
2026-06-12 16:03 2mo ago
2026-05-13 22:39 3mo ago
Provident Adds Exposure to Delek and the Energy Sector
DK Delek US Energy
FMP Stock News
Original source text
What happenedAccording to a SEC filing dated May 12, 2026, Provident Co of the Employees of the Hebrew University reported a new position in Delek US Holdings (DK +2.00%), buying 72,679 shares during the first quarter. The estimated transaction value was $2.60 million, based on average unadjusted closing prices from January through March 2026. The stake’s quarter-end value was $3.28 million, reflecting both share additions and market price movement.

What else to knowThis new position in DK represents 5.17% of the fund’s 13F reportable assets under management as of March 31, 2026.Top five holdings after the filing:NYSEMKT:EPI: $6.34 million (10.0% of AUM)NYSEMKT:XLI: $5.93 million (9.4% of AUM)NYSEMKT:PAVE: $5.28 million (8.3% of AUM)NASDAQ:AMZN: $4.83 million (7.6% of AUM)NASDAQ:SMH: $3.94 million (6.2% of AUM)As of May 13, 2026, DK shares were priced at $53.88, up 153.2% over the past year, outperforming the S&P 500 by 126.74 percentage points.Company overviewMetricValueRevenue (TTM)$10.73 billionNet income (TTM)($51.40 million)Dividend yield2.18%Price (as of market close May 13, 2026)$43.88Company snapshotProduces and markets refined petroleum products, including gasoline, diesel, jet fuel, and asphalt, and operates convenience retail stores primarily in the southern United States.Operates an integrated downstream model with refining, logistics, and retail segments, generating revenue from fuel production, wholesale distribution, and convenience store operations.Serves oil companies, independent refiners, marketers, jobbers, distributors, utilities, transportation companies, the U.S. government, and independent retail fuel operators.Delek US Holdings, Inc. is a diversified energy company with a significant presence in refining, logistics, and retail fuel distribution across the southern United States. The company leverages its integrated business model to optimize margins and operational efficiency, supported by strategically located refineries and a robust pipeline and terminal network.

With a focus on both wholesale and retail markets, Delek US Holdings aims to capture value across the downstream energy chain, maintaining a competitive position through scale, logistics infrastructure, and a broad customer base.

What this transaction means for investorsProvident, an employee pension fund connected to Hebrew University in Jerusalem, typically takes a long-term, diversified approach to investing. This recent purchase shows a continued interest in growth-oriented stocks and a willingness to tolerate some short-term volatility when a company’s business fundamentals seem sound.

Like many energy companies, Delek has experienced volatility due to geopolitics, shifting energy demand, and regulatory uncertainty. Still, the company beat analysts’ estimates for the first quarter of 2026, and its stock has performed well over the past year. Though it reported a trailing-12-month net income of negative 51.40 million, the company has continued expanding its refinery and midstream infrastructure. It is also pursuing an EPA renewable-fuel exemption for small refineries that would improve its profitability.

Investors who want exposure to the energy sector, particularly petroleum refining and midstream operations, may find Delek an interesting option. But for those with a lower risk tolerance or shorter investment horizon, a diversified energy ETF such as Energy Select Sector SPDR Fund (XLE +1.76%) might be a better fit.

Pamela Kock has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amazon. The Motley Fool recommends Delek Us. The Motley Fool has a disclosure policy.
2026-06-12 16:03 2mo ago
2026-05-18 05:55 3mo ago
Best Value Stocks to Buy for May 18th
DK Delek US Energy
FMP Stock News
Original source text
Here are three stocks with buy rank and strong value characteristics for investors to consider today, May 18:

Kohl's Corporation (KSS - Free Report) : This retail company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing by 6.1% over the last 60 days.

Kohl's has a price-to-earnings ratio (P/E) of 14.38 compared with 21.50 for the industry. The company possesses a Value Scoreof A.

Delek US Holdings, Inc. (DK - Free Report) : This downstream energy company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing by 1521% over the last 60 days.

Delek US Holdings has a price-to-earnings ratio (P/E) of 9.88 compared with 12.40 for the industry. The company possesses a Value Score of A.

Versant Media Group, Inc. (VSNT - Free Report) : This entertainment company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its next year earnings increasing 14.3% over the last 60 days.

Versant has a price-to-earnings ratio (P/E) of 10.17 compared with 178.40 for the industry. The company possesses a Value Score of A.

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.
2026-06-12 16:03 2mo ago
2026-05-18 11:01 3mo ago
Best Momentum Stocks to Buy for May 18th
DK Delek US Energy
FMP Stock News
Original source text
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 18:

SiTime Corporation (SITM - Free Report) : This timing semiconductor company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 95.2% over the last 60 days.

SiTime's shares gained 203% over the last three months compared with the S&P 500’s decline of 8.4%. The company possesses a Momentum Score of A.

Delek US Holdings, Inc. (DK - Free Report) : This downstream energy company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1521% over the last 60 days.

Delek’s shares gained 32.4% over the last three months compared with the S&P 500’s decline of 8.3%. The company possesses a Momentum Score of A.

Okeanis Eco Tankers Corp. (ECO - Free Report) : This shipping company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 119.1% over the last 60 days.

Okeanis Eco Tankers’ shares gained 119% over the last three months compared with the S&P 500’s decline of 8.3%. The company possesses a Momentum Score of B.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.
2026-06-12 16:03 2mo ago
2026-05-20 02:26 3mo ago
Best Growth Stocks to Buy for May 20th
DK Delek US Energy
FMP Stock News
Original source text
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, May 20:

Valero Energy Corporation (VLO - Free Report) : This energy company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 111.2% over the last 60 days.

Valero has a PEG ratio of 0.36 compared with 0.49 for the industry. The company possesses a Growth Score of B.

Delek US Holdings, Inc. (DK - Free Report) : This integrated downstream energy company carriesa Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1521.4% over the last 60 days.

Delek US Holdings has a PEG ratio of 0.34 compared with 0.49 for the industry. The company possesses a Growth Score of A.

Pitney Bowes Inc. (PBI - Free Report) : This digital shipping and mailing solutions company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 11% over the last 60 days.

Pitney Bowes has a PEG ratio of 0.74 compared with 0.75 for the industry. The company possesses a Growth Score of A.

See the full list of top-ranked stocks here.

Learn more about the Growth score and how it is calculated here.
2026-06-12 16:03 2mo ago
2026-05-21 20:29 3mo ago
Delek US Holdings Inc (DK) Stock Down 5.6% but Still Overvalued -- GF Score: 55/100
DK Delek US Energy
FMP Stock News
Original source text
On May 21, 2026, Delek US Holdings Inc (DK) shares fell 5.6% to a current price of $42.10. The stock has seen significant volatility, trading within a 52-week r
2026-06-12 16:03 2mo ago
2026-05-22 00:21 3mo ago
Best Growth Stocks to Buy for May 22nd
DK Delek US Energy
FMP Stock News
Original source text
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, May 22:

Valero Energy Corporation (VLO - Free Report) : This energy company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 100.1% over the last 60 days.

Valero has a PEG ratio of 0.37 compared with 0.49 for the industry. The company possesses a Growth Score of B.

Delek US Holdings, Inc. (DK - Free Report) : This integrated downstream energy company carriesa Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1161.1% over the last 60 days.

Delek US Holdings has a PEG ratio of 0.33 compared with 0.49 for the industry. The company possesses a Growth Score of A.

Pitney Bowes Inc. (PBI - Free Report) : This digital shipping and mailing solutions company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 11% over the last 60 days.

Pitney Bowes has a PEG ratio of 0.69 compared with 0.74 for the industry. The company possesses a Growth Score of A.

See the full list of top-ranked stocks here.

Learn more about the Growth score and how it is calculated here.
2026-06-12 16:03 2mo ago
2026-05-26 12:45 3mo ago
Is Delek US Holdings Stock Overpriced in 2026?
DK Delek US Energy
FMP Stock News
Original source text
Sometimes, stocks catch lightning in a bottle. Delek US Holdings (DK +2.00%) is a good example. Over the past 12 months, shares of the integrated energy refiner have jumped 122%.

It sure helps when energy stocks and small-cap equities, of which Delek is both, are simultaneously displaying leadership traits. With the stock up 47% year to date but about 12% below its 52-week high, it's in correction territory, raising concerns that the shares are overvalued. Some market observers may argue that the stock is significantly overvalued.

This energy stock may be more undervalued than meets the eye. Image source: Getty Images

Stoking those valuation worries is the point that there's been some recent insider selling at the Tennessee-based energy company. At any company, directors and high-ranking executives sell shares for various reasons. Sometimes it's as simple as diversifying their personal portfolios, but at other times those transactions signal valuation concerns.

However, that's not necessarily the case with Delek. Actually, some signs point to the stock being undervalued. Here's why.

Trapping value, but not a value trap In the eyes of some investors, Delek's value case centers on its 63.3% interest in Delek Logistics Partners (DKL 4.01%), a midstream crude oil gatherer, processor, and transporter of refined energy products. The logistics business has a market capitalization of $2.8 billion, meaning Delek's stake is worth nearly $1.8 billion, implying the refiner could unlock significant value for shareholders by spinning off or selling or a portion of that interest.

By some estimates, Delek's stake in the logistics business could be worth more than its entire market capitalization, and by taking action on that position, the company could unlock $600 million to $700 million of "trapped" shareholder value.

Inquiring investors will want to know whether it makes sense for Delek to pursue value creation by trimming or parting ways with its economic position in Delek Logistics. The answer is a resounding "yes" because the business has long been undervalued but is growing. Delek Logistics posted a 5.8% increase in first-quarter revenue, and it's generating more earnings and sales from third-party entities, meaning its dependence on Delek is declining.

Today's Change

(

2.00

%) $

0.94

Current Price

$

48.01

Investors often covet unencumbered midstream businesses for their predictable, toll-road-like business models. Likewise, refiners freeing themselves of midstream obligations can command capital injections to bolster infrastructure and improve existing operations. There's also plenty of precedent for refiners or integrated oil companies to spin off midstream assets, with a slew of such transactions taking place in the early 2010s.

The point is that the market may not be critical of Delek dumping its logistics investment. Investors may applaud the move.

Delek has other attractive traits With a market capitalization of $2.6 billion, Delek is just above the strict definition of a small-cap stock, which is capped at $2 billion. Many small caps aren't cheap on valuation because that's the price of admission investors pay for accessing, hopefully, attractive growth prospects.

And there are some things to "nitpick" with Delek. It lacks the scale of Marathon Petroleum and Valero Energy, and its debt-to-equity ratio is higher than theirs. On the bright side, Delek is reducing debt, and it has $624 million in cash.

Bargain hunters can take heart in knowing that, based on price/operating cash flow and enterprise value/revenue, Delek is one of the most discounted names in the energy refining sector.
2026-06-12 16:03 2mo ago
2026-06-03 13:16 3mo ago
Delek Surges 149% in a Year: How to Approach the Stock?
DK Delek US Energy
FMP Stock News
Original source text
Key Takeaways DK gained 149.3% in a year, outperforming peers and broader energy benchmarks.DK raised its Enterprise Optimization Plan target to at least $220 million annually.DK faces 2026 earnings pressure, higher RIN costs and a $2.56 billion net debt load. Shares of Delek US Holdings, Inc. (DK - Free Report) gained momentum over the last year, following a staggering rise of 149.3%. During the same time period, the company’s shares outperformed the sub-industry and the broader oil and energy sector’s rally of 59% and 37.8%, respectively.

Peer comparison further highlights the strength, as Delek conveniently outperformed its peers, CVR Energy, Inc. (CVI - Free Report) and Phillips 66 (PSX - Free Report) , which gained 52.3% and 62.7%, respectively, in the past year.

Image Source: Zacks Investment Research

Delek operates in a refining industry that continues to benefit from supportive market fundamentals, including tight fuel inventories, resilient demand and favorable access to domestic crude supplies. The company has also gained from regulatory relief and stronger refining margins driven by recent geopolitical disruptions. However, refining remains a highly cyclical business, with profitability closely linked to volatile crude prices, crack spreads and changing market conditions. While current industry trends provide meaningful upside support, the inherent uncertainty surrounding refining economics and commodity markets warrants closer scrutiny.

Factors Favoring Delek StockEnterprise Optimization Plan (EOP) Is Driving Structural Free Cash Flow Growth: Delek's Enterprise Optimization Plan continues to exceed expectations, with management raising the annual run-rate target for the sixth consecutive time to at least $220 million from the prior $200 million target. The program is no longer focused solely on cost reduction but also on margin enhancement, logistics optimization, higher product yields and improved commercial execution. Management estimated roughly $60 million of EOP contribution in the first quarter alone and believes additional opportunities remain. The initiative has already improved profitability at key assets such as El Dorado and is helping lower refining breakevens. As these benefits become fully embedded, Delek could generate substantially higher free cash flow even in a mid-cycle refining environment.

Image Source: Delek US Holdings

Big Spring Turnaround Creates a Strong Earnings Setup for the Rest of 2026: The company successfully completed the major Big Spring refinery turnaround safely, on time, and on budget. More importantly, the turnaround was designed to improve reliability, crude slate flexibility, product yields and higher-octane blending capabilities. Since the project represented the largest planned maintenance event of the year, management indicated that the highest spending quarter is now behind them, with no significant turnarounds planned for the remainder of 2026. This positions Delek to fully capitalize on stronger summer fuel demand and favorable refining margins while simultaneously benefiting from lower maintenance-related disruptions and capital spending.

Advantaged Refining Position in the Current Market Environment: Management repeatedly emphasized that Delek's refining system is particularly well positioned due to its direct access to domestic crude supplies, extensive logistics network, and one of the industry's highest distillate and jet fuel yields. Ongoing geopolitical disruptions have tightened global fuel markets and increased the value of refiners with reliable crude access and strong middle-distillate production. Delek's connectivity to multiple domestic crude sources and exposure to both Gulf Coast and Mid-Continent markets provide flexibility that many competitors lack. If current market conditions persist, the company could achieve superior margin capture relative to peers.

Challenges That Pressure DK Stock2026 Earnings Estimates: The Zacks Consensus Estimate implies a 24.9% year-over-year decline in DK’s 2026 earnings per share, signaling a shift to negative earnings growth. This anticipated decline contrasts with the optimism embedded in the stock’s current price. In other words, investors are paying up for Delek at a point when fundamentals are expected to cool rather than accelerate. Unlike DK, the Zacks Consensus Estimate for 2026 earnings per share of peer companies — CVR Energy and Phillips 66 — implies a positive year-over-year earnings growth of 185.3% and 174%, respectively.

Image Source: Zacks Investment Research

Large Renewable Fuel (RIN) Obligations Create Significant Risk: The Renewable Fuel Standard remains one of the company's biggest financial challenges. Management disclosed that at a $1.50 blended RIN price, Delek's 2026 compliance obligation could reach approximately $750 million. Furthermore, the company noted that expected 2026 compliance costs are running roughly 41% higher than 2025 levels. Rising RIN prices could substantially pressure profitability, especially if expected exemptions are not granted. This creates a major external risk that management cannot fully control and could significantly affect shareholder returns.

Elevated Debt and Interest Burden Could Limit Flexibility: Although Delek's standalone balance sheet has improved, the consolidated enterprise still carries substantial debt. At the end of the first quarter of 2026, consolidated net debt stood at approximately $2.56 billion, while management expects quarterly net interest expense of $80-$90 million. Such leverage increases sensitivity to downturns in refining margins and can limit financial flexibility during weaker industry cycles. While the midstream segment helps support cash flows, investors must weigh the benefits of shareholder returns against the ongoing burden of servicing a sizeable debt load in a cyclical business.

Final Verdict on DK StockThis Zacks Rank #3 (Hold) company is benefiting from strong execution of its Enterprise Optimization Plan, which continues to drive structural free cash flow improvements, a completed Big Spring refinery turnaround that enhances operational efficiency, a favorable refining position supported by reliable domestic crude access, strong distillate yields, along with continued strong stock price performance — outpacing peers like CVR Energy and Phillips 66.

However, these strengths are countered by significant concerns, including an expected decline in 2026 earnings, substantial RIN compliance costs and a sizable debt burden that could restrict flexibility during weaker refining cycles.

In this context, investors should consider adopting a hold strategy for now to monitor Delek’s ongoing strengths while waiting for clearer earnings visibility and avoiding a premature exit before its initiatives potentially translate into shareholder value.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
2026-06-12 16:03 2mo ago
2026-06-08 12:41 3mo ago
How Delek's Strong Enterprise Optimization Plan Boosts Its Cash Flow
DK Delek US Energy
FMP Stock News
Original source text
Key Takeaways DK raised EOP's annual run-rate target to at least $220M, the sixth increase since launch.DK's EOP added about $60M to Q1 2026 profit through efficiency gains.Delek targets stronger cash flow via margin gains, logistics upgrades and lower costs. Delek US Holdings, Inc.’s (DK - Free Report) Enterprise Optimization Plan (EOP) has become a key driver of the company’s financial transformation. Designed to improve operational efficiency, reduce costs and enhance asset performance, the initiative is steadily strengthening Delek’s cash flow generation. As refining margins remain volatile, EOP is helping the company build a more resilient business model, positioning it to deliver stronger free cash flow and greater shareholder value. Since its launch, the program has exceeded expectations, prompting management to raise its annual run-rate target for the sixth consecutive time, most recently to at least $220 million from the previous $200 million target. During the first quarter of 2026, EOP contributed approximately $60 million to Delek’s profit.

Unlike a traditional cost-cutting program, Delek’s EOP focuses on optimizing the entire value chain. The initiative combines margin enhancement, logistics improvements, supply-chain optimization, higher product yields, reduced general and administrative expenses and lower financial costs. Management estimates that roughly $150 million of the targeted benefits will come from stronger margins, while another $70 million will be generated through efficient cost structures.

The plan has already delivered tangible operational benefits. At the El Dorado refinery, EOP initiatives have improved gross margins through enhanced logistics and lower operating costs. Across the refining network, EOP-driven projects have helped increase distillate and jet fuel yields, supporting stronger profitability.

Most importantly, EOP is helping Delek generate more cash without relying on major capital investments. Combined with limited turnaround activity and improved operational reliability, the program is positioning the company to produce substantially higher free cash flow, strengthen shareholder returns and create long-term value across market cycles.

Other Refining Companies’ Strategy to Boost Cash FlowPhillips 66 (PSX - Free Report) has been focused on strengthening cash flow through operational excellence, disciplined capital allocation and working capital management. Despite a first-quarter cash outflow driven by inventory builds and margin collateral requirements, PSX generated $700 million in operating cash flow excluding working capital. Management expects significant working capital recovery over the remainder of 2026 as market conditions stabilize, providing a cash flow tailwind. Phillips 66 is also leveraging its global trading, logistics and refining network to capture higher margins. Strong expected operating cash flow, coupled with cost-reduction initiatives, is expected to support debt reduction while continuing shareholder returns.

Marathon Petroleum Corporation (MPC - Free Report) improves its cash flow through a combination of operational excellence, disciplined capital allocation and growth investments. In the first quarter, the company generated $1.7 billion in operating cash flow excluding working capital, 99% capture rates and high refinery utilization. MPC continues to invest in high-return projects such as jet fuel capacity expansions at Garyville and Robinson to enhance profitability and future cash generation. Additionally, its midstream subsidiary MPLX is expanding natural gas and NGL infrastructure, creating durable cash flows. Strong commercial execution and strategic investments enable Marathon Petroleum to generate substantial cash while supporting shareholder returns.

The Zacks Rundown for DelekShares of Delek have soared 154.6% in the past year, outperforming the Oil/Energy sector’s rise of 35%.

Image Source: Zacks Investment Research

From a valuation perspective — in terms of the forward price-to-sales ratio — Delek is trading at a discount compared with the industry average.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for Delek’s 2026 earnings has been revised about 24.3% upward over the past 30 days.

Image Source: Zacks Investment Research

The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
2026-06-12 16:03 2mo ago
2026-06-10 12:30 3mo ago
1 Underappreciated Energy Stock You Won't Want to Overlook
DK Delek US Energy
FMP Stock News
Original source text
Combining the listings on the Nasdaq stock exchange, the New York Stock Exchange (NYSE), and the over-the-counter (OTC) markets, over 12,000 stocks are trading in the U.S. That number is certainly large enough to ensure plenty of promising names go overlooked or underappreciated.

Arguably, that's the plight of refiner Delek US Holdings (DK +2.00%). At a time when the energy sector and smaller stocks are soaring, Delek, with a market capitalization of just under $3 billion, should be attracting more attention.

The reality is the stock leads an arguably anonymous existence, which is really odd given its 64% year-to-date gain.

This energy stock flies under the radar, but that may not last long. Image source: Getty Images.

However, it's not completely ignored. Up more than 13% since May 26, Delek is covered by 13 sell-side analysts, confirming that Wall Street is aware of this stock. That may be a sign Delek's overlooked status could change in a heartbeat, indicating that astute investors may want to examine the name here and now.

Delek is unique among refiners Investors experienced with oil stocks know this is an industry where scale matters. That sentiment extends to the downstream space, where companies such as Marathon Petroleum and Valero process millions of barrels per day, well above the 302,000 barrels Delek handles. Said another way, many investors tend to "go big" with refining stocks.

However, there are benefits in Delek's approach, which some experts describe as "surgical." The company can make small changes that wouldn't move the needle at Marathon or a Valero, but are meaningful to a company that's barely out of small-cap territory. Unveiled in 2022, Delek's enterprise optimization program "trims fat" by cutting overhead and reducing waste. It doesn't sound "sexy," but that effort may be a contributing factor in the stock more than doubling over the past three years.

Delek's surgical approach bears fruit in other ways. Its first-quarter results confirm as much. Revenue of $2.52 billion was basically in line with what it posted a year earlier, but Delek drummed up a fivefold increase in earnings before interest, taxes, depreciation, and amortization (EBITDA). Translation: Delek's tactical operating methods fostered significantly higher earnings without needing similarly increasing revenue.

Today's Change

(

2.00

%) $

0.94

Current Price

$

48.01

This favorable story hasn't been entirely lost on Wall Street. In April, Goldman Sachs lifted its price target on the stock to $55 (it closed at $48.48 on June 8), citing cost-cutting efforts, enhanced marketing and wholesale strategies, and improving earnings, among other factors.

Delek has the capacity for shareholder rewards Delek's stock currently yields 2.1%, so it merits consideration in the oil dividend stock conversation. In the first three months of 2026, the company spent $15.6 million on dividends and ended the period with $624.1 million in cash, indicating it has the ability to sustain, if not grow, the payout.

The refiner has also shown a willingness to repurchase its shares and trimmed $53 million in debt in the first quarter, indicating it's committed to shoring up its balance sheet.

Delek isn't perfect. Its debt ratio is high compared to those of its larger competitors, and refining margins are notoriously volatile. Still, as the company's good-news story takes shape, the stock shouldn't remain overlooked for long.